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ABSTRACT 
Water samples were collected during seven sampling periods between 
August 2001 and March 2003 at twenty-four sites along the Triplett creek 
water shed in Rowan County, Kentucky. The water samples were filtered by 
membrane filtration and M-endo, M-FC and M-enterococci media used to 
isolate total coliforms, fecal coliforms and fecal streptococci, respectively. 
Bacterial counts were determined and fecal coliform: fecal streptococci ratios 
were generated to determine the presumptive source of contamination. 
According to the ratios, eight percent of the isolates appeared to be from a 
presumptive human source, fifty percent were from a potential mix of human 
and animal contamination, and forty two percent came from a presumptive 
animal source. One hundred and thirty two of the fecal coliform isolates were 
evaluated for resistance to six - seven classes of antibiotics by the Kirby Bauer 
disc diffusion method. Based upon the fecal coliform: fecal streptococci 
ratios generated, presumptive human source isolates appear to exhibit a higher 
percentage of resistance for streptomycin, amikacin, trimethoprim, cefalozin, 
and ampicillin, than presumptive animal source isolates. In clinical enteric 
isolates antibiotic resistance has been highly correlated with the presence of 
integrons. Thus polymerase chain reaction was used to evaluate one hundred 
and twenty six of the isolates for the presence of class I and class 2 integrons 
to access the presence of integrons in environmental enteric bacteria. Nine of 
isolates appeared to possess a class 1 integron. Two of the class 1 integron 
positive isolates presumptively came from a source of predominately animal 
contamination while seven of the integron positive isolates appear to be from 
a mix of human and animal contamination. Only three of the isolates 
exhibited resistance to antibiotics. Previous studies have reported the 
presence of empty integrons, or integrons not carrying resistance gene 
cassettes, in environmental isolates. None of the isolates appeared to possess 
a class 2 integron. 
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Introduction 
Because bacteria must live and survive under continuously changing, often 
harsh environments, they are forced to adapt. They have thus evolved strategies that 
allow the generation of genetic diversity. Point mutation, recombination events 
between homologous DNA, and transposable elements, as well as the acquisition of 
exogenous DNA via horizontal gene transfer, contribute to the development of new 
variants (20, 37). In recent years, there has been an increase in the number of 
antibiotic resistant and multiple drug resistant microbes observed in clinical settings, 
especially among members of the family Enterobacteriaceace. As a result, these 
resistant microbes are becoming increasingly difficult to treat (12,21). 
Because many species of this family coexist in the intestinal tract and are 
frequently exposed to various antibiotics, there exists the potential for the 
development and propagation of antibiotic resistance genes. When these antibiotic 
resistance genes become clustered as part of mobile genetic elements, they impart 
resistance to several antibiotics in those microbes containing them. 
Integrons are one such genetic element that have been implicated in resistance 
among clinical enteric isolates. Therefore, the presence of integrons in bacterial 
species that constitute the family Enterobacteriaceace is of interest with respect to the 
growing dilemma of antibiotic resistance. However, few studies have looked at the 
role of integrons in the environment and a possible correlation with the antibiotic 
resistance observed in environmental isolates (12). 
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The Family Enterobacteriaceae 
Members of the family Enterobacteriaceace are facultatively anaerobic, 
gram-negative bacilli and include both pathogenic and non-pathogenic species. They 
are a very diverse, widespread group. 
Coliforms are members of the family Enterobacteriaceae that ferment lactose 
with gas production in 48 hours at 35°C. Fecal coliforms are a subset of the group 
that inhabit the intestinal tracts of humans and other warm-blooded vertebrates and 
can grow at the more restrictive temperature of 44.5°C. As a group, they are not 
generally considered pathogenic but if present in water can indic::ite the presence of 
fecal contamination and thus the potential presence of pathogenic species. 
Escherichia coli is the most common member. 
Fecal streptococci consist of gram-positive cocci belonging to the genera 
Streptococcus and Enterococcus. They also normally inhabit the intestinal tract of 
warm-blooded animals. There is some question as to their use as a water quality 
indicator because they exhibit variable survival in water environments. 
Antibiotics 
The 13-lactam antibiotics comprise a group of diverse and commonly used 
antibiotics, They include penicillins, (including carbenicillin and the 
aminopenicillins such as piperacillin and ampicillin), cephalosporins, and 
carbenpenems. Their basic structure is composed of a 13-lactam ring and they inhibit 
cell wall synthesis by acting on penicillin binding proteins (PBP) (13). 
Cephalosporins are produced from fungi belonging to the genus 
Cephalosporium. They inhibit cell wall synthesis in both gram negative and gram 
positive bacteria. 
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Streptomycin was the first aminoglycoside discovered in I 944; Kanomycin, 
gentamicin and tobramycin were soon discovered afterward. Amikacin, a semi-
synthetic aminoglycoside,_was developed in the 1970's (18). In general, the 
aminoglycosides exhibit a broad spectrum of activity and are used to treat both gram-
negative and gram-positive infections. Aminoglycosides interfere with protein 
synthesis by binding to the ribosome and can be bactericidal or bacteriostatic (13). 
They are highly polar molecules and transverse the outer membrane of gram-negative 
bacteria by drug induced disruption of Mg2+ bridges between neighboring 
lipopolysaccharide molecules. Aminoglycosides cannot pass through porin channels 
due to their large size. In the second phase of transport, termed energy dependent 
phase I (EDP-I), transport across the cytoplasmic membrane is dependent upon 
electron transport (18). 
Fluoroquinolones, including ciprofloxin, were introduced in the 1980's as 
broad-spectrum antibiotics used to treat a variety of gram-negative infections f26). 
They act by inhibiting bacterial topoisomerase II (DNA gyrase) and IV (13, 26). 
·Both enzymes are composed of-two subunits designated A (genes gyr A and gyrB for 
topoisomerase II) and B (genes parC and parE) (13). 
Macrolides are a widely used group of antibiotics. In the 1980's, 10-15% and 
18% in the 1990's, of the world's antibiotic consumption could be contributed to 
macrolide consumption ( I 0). The basis of the macrolide stmcture is a large multi -
membered lactone ring with one or more amino sugars attached (I 8, 33). They are 
grouped based on the size of the lactone ring, which commonly consist of 12, 14, 15, 
I 6 membered ring groups. The 14 membered ring group consists of naturally 
occurring compounds such as erythromycin. Macrolides act by binding to the 50s 
ribosomal subunit, inhibiting elongation as well as the initial steps in 50s ribosomal 
assembly (33). 
Tetracyclines are broad-spectmm antibiotics active against a range of gram 
negative and gram-positive bacteria (9). They inhibit protein synthesis by binding to 
the 30s ribosomal subunit, preventing association with aminoacyl tRNA (9, 13). 
Tetracyclines are bacteriostatic because ribosome binding is reversible. In gram 
negative enterics, tetracyclines negotiate a path across the outer membrane through 
the OmpF and OmpC porin channels by associating with a positively charged metal 
ion ( commonly magnesium). The cation-tetracycline complex accumulates in the 
periplasm were the metal ion dissociates and the antibiotic diffuses across the 
cytoplasmic (inner) membrane. Uptake across the inner membrane is energy 
dependent and is driven by a proton motive force (9). 
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As a group, tetracyclines have been used extensively in the treatment of a 
variety.of human and animal infections. In addition, they are added at subtherapeutic 
levels in animal feeds to act as growth promoters and are also used prophylactically in 
the prevention of malaria. As a result of their prevalent use, many resistance 
determinants have been described. Many of the tetracyclines, tetracycline for 
example, are natural products of Streptomyces species, while others, such as 
doxycycline are semi synthetic products. Both tetracycline and doxycycline are 
considered first generation tetracyclines (9). 
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Trimethoprim, a sulfonamide, is an analog of dihydrofolic acid, and a 
competitive inhibiter of dihydrofolate reductase (DHFR; 13). Dihydrofolic acid is an 
essential component in amino acid and nucleotide biosynthesis. 
Mechanisms of Resistance 
Resistance to antibiotics generally occurs by four mechanisms: modification 
of the antibiotic, efflux pumps (decreased uptake), altered antibiotic target, and 
production of an alternative target (Figure 1 ). Antibiotic resistance in bacteria can be 
described as intrinsic or acquired. Intrinsic resistance occurs naturally due to the 
specific biology of the organism. Acquired resistance occurs when the organism 
normally sensitive to an antibiotic develops resistance through mutation or via 
acquisition of exogenous DNA (horizontal gene transfer, HGT) that confers 
resistance (15). Mutation occurs independent of the presence of the antibiotic. In the 
presence of antibiotic, susceptible cells are rapidly killed, while those cells carrying a 
mutation conferring resistance survive. Thus, the antibiotic selects for a resistant 
subpopulation. 
Antibiotic modification is the most common mechanism observed. Both the 
resistance and sensitive strains possess the same sensitive target but the resistant 
strain cleaves or alters the target in such a way that it prevents the antibiotic from 








Figure I. Four major mechanisms ofamihiotic n:sistance (15). 
Decreased uptake involves preventing antihiotic access to the bacterial cell 
and/or pumping the antibiotic out at a rate faster than it can Ihm in. This is 
accomplished by specific transport proteins collccti\'d~ n:li:rrcd to as efflux pumps 
(34). Resistance via antibiotic efflux was first descrihcd in the early I 980's for 
tetracycline and has since been described for many antibiotics. in a variety of 
bacterial species ( 4, 26). Efflux systems generally confer low to intermediate level 
resistance. However, expression of several efflux pumps in a species or efflux in 
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conjunction with other resistance mechanisms may result in high-level resistance as 
well as broad-spectrum resistance (26). 
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Efflux pumps can generally be grouped in two major classes, secondary 
multidrug transporters and ATP binding cassettes. Secondary multidrug transporters 
use proton motive force to expel the antibiotic from the cell, while ABC-type multi-
drug transporters accomplish the task by hydrolyzing ATP (Figure 2; 28). 
A 







Figure 2. Two classes of multidrug transporters. (A) ABC-type transporters 
utilize ATP to pump substrates such as antibiotics from the cell. (B) 
Secondary transporters mediate the extrusion of drugs from the cell in a 
coupled exchange with hydrogen or sodium ions. (Figure modified from 28) 
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Secondary multidrug transporters can further be divided into four families: the 
major facilitator superfamily (MFS), the resistance-nodulation-division (RND), the 
small multi-drug resistance family (SMR), and the multi-drug and toxic compound 
extrusion family (MATE) (Figure 3; 28). Generally, antibiotic efflux pumps are 
members of the RND, MFS, or MA TE families. RND transporters are unique to 
gram negative bacteria and generally utilize another protein, the periplasmic 
membrane fusion protein (MFP), also known as the periplasmic efflux protein or 
outer membrane protein). This allows the antibiotic to be transported across both 
membranes in gram-negative bacteria (26). 
Some efflux pumps exhibit specificity in the type of antibiotic exported, while 
others referred to as multi-drug resistance pumps (MDR) exhibit broader range and 
export antibiotics from various classes. Efflux pumps can be single or multi 
component systems (Figure 3). Single component efflux systems expel their 
substrates into the periplasmic space in gram-negative bacteria. An example of such 
a system is found chromosomally located in E. coli. It is a transposon associated, 
tetracycline and chloramphenicol specific (TetA and CmlA; respectively) MDR pump 
termed MdfA. Multi-component systems are found only in gram negative bacteria 
and span both the inner and outer membrane. Each pump in such a system is 
composed of an inner membrane transporter, an outer membrane channel, and a 
periplasmic space linker protein (Figure 3; 19). 
Resistance to the aminoglycosides can be contributed to aminoglycoside 











Figure 3. Schematic representing the organization of multi component and single 
component efflux pumps. The multi component pumps, RND and MFS are unique to 
gram-negative bacteria. The RND, MFS and MATE systems utilize an ion gradient 
to transport the antibiotic out of the cell. OM, outer membrane; PP, periplasmic 
space; CM, cytoplasmic membrane. (26) 
systems (34), as well as mutations in the rRNA (13), can impart intermediate 
resistance. Over 50 aminoglycoside modifying enzymes have been described, most 
of which are found in gram negative isolates. These enzymes are divided into three 
groups based on the type of modification: aminoglycoside acetyltransferases (AAC), 
aminoglycoside adenylytransferases (Aminoglycoside nucleotidyltransferases (ANT) 
and the aminoglycoside phosphotransferases (APH). These groups can further be 
. divided into sub classes based on the substrates modified (13). The enzymes act by 
covalently modifying specific amino or hydroxy functions, which results in poor 
binding to the ribosome (34). 
AAC enzymes use acetyl CoA as donor and affect amino functions. ANT 
and APH use ATP as a donor and affect hydroxyl functions. It has been suggested 
that these genes play a necessary function in the natural environment of wild type 
strains, such as acetylation or phosphorylation of nan1ral substrates. It is speculated 
that under the pressure of the antibiotic these genes are over expressed and the 
antibiotics serve as substrates (34). 
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Resistance to fluoroquinolones generally occurs by two mechanisms, altering 
the drug target (topoisomerase enzymes) or decreased drug uptake. It appears that 
alteration of the topoisomerase enzymes is the most common mechanism of 
resistance. In gram negative bacteria, topoisomerase II is the primary drug target, 
whereas the target in gram positive bacteria depends upon the species and quinolone 
structure. In E. coli the codon regions 67_-106 of gyrA has been called the quinolone 
resistance-determining region (QRDR; 13). Increased efflux has also been reported 
to confer low level resistance to fluoroquinolones in gram negative isolates, including 
E. coli, Enterobacter aerogenes, and Klebsiella pneumonia (13, 26). 
Gram negative enterics, such as E. coli, are intrinsically resistant to 
macrolides due to the structure of their outer mt,mbrane (33). 
Tet_racycline increased resistance by efflux or ribosomal mutation has been 
observed in first and second-generation species. 
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Resistance to trimethoprim can be contributed to overproduction of host 
DHFR, mutations in the DHFR gene itself, or the acquisition of the dfi· gene, which 
encodes a resistant form of the DHFR enzyme. Approximately 15 DHFR enzymes 
have been described. The most common mechanism oftrimethoprim resistance in 
Enterobacteriaceae is due to alternative forms of the DHFR, mainly of type I, II, or V 
(13). 
~-lactamases are bacterial enzymes that catalyze the hydrolysis of ~-lactam 
antibiotics. Resistance by mutations in PBPs also can result in reduced binding 
affinity and confer resistance. Although it is less common, resistance can also be 
attributed to reduced uptake via efflux. TEM I ~- lactamase is a ~- lactamase 
common in gram-negative bacteria and can hydrolyze both penicillin and non-
extended spectrum cephalosporins (7). All gram-negative bacteria harbor 
chromosomally .encoded ~-lactamases. They are generally expressed at low levels in 
non-human coliforms but can be induced by ~-lactam antibiotics. There is an 
increasing amount of plasmid derived extended spectrum ~-lactamases, most of 
which are derived from the TEM or SHY -1-~-lactamases. Acquisition of plasmids 
harboring chromosomal ~-lactamases from Citrobacter, Enterobacter, and 
Pseudomonas by E. coli and Klebsiella pneumonia also confer additional ~-lactamase 
resistance (11 ). 
Antibiotic Resistance Genes 
Resistance contributed to efflux pumps can be found in both gram negative 
and gram-positive bacteria. In most instances the genes encoding the efflux pump 
proteins are part of an operon with expression regulated by a regulatory gene. Over 
expression can lead to the antibiotic resistant phenotype. In E. coli, efflux derived 
resistance is often mediated by over expression of acrA. (35). 
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Different classification systems exist to group the P-lactamases. One system 
is based on their nucleotide sequence and designated classes A through D. Class A, 
C, and D enzymes have a serine at their active site, while Class B enzymes have four 
zinc atoms at their active site. Class A encompasses the extended spectrum P-
lactamases (ESBLs). Class C genes are generally inducible and over expression can 
result from mutations in the genes (13). 
Although most ESBLs in Enterics are contributed to TEM derivates, a 
growing number of class C P-lactamases are similar to the amp C genes in 
Citrobacterji·eundii (CMY-2, CMY2b, LAT-1, LAT-2 and BIL-1), Enterobacter 
cloacae (MIR-I and ACT-1),Morganella morganii (DHA-1) and others of unknown 
origin (CMY-1, MOX-I and FOX-1-3). 
Resistance to tetracyclines is attributed to the acquisition of tel genes. Tel 
genes were first described in enterics and pseudomonads, but because they are often 
associated with transposons, plasmids, and integrons, they are now widespread. 
Approximately 29 tetracycline resistant (tel) genes and oxytetracycline resistant (otr) 
genes have been described. There is no intrinsic difference in the air genes; they 
were simply discovered first in oxytetracycline producing organisms (9). Table 1 
indicates the mechanism ofresistance by tel and otr genes. Table 2 shows the 
distribution of tet genes in Eschericheria and Klebsiella. 
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The tet genes coding for efflux proteins are the best characterized tet proteins 
(9). 
Table 1. Mechanism of resistance by tel and otr genes. 
Efflux 







tet(M), tet(O), 1e1(S), tet(W) 
tet(Q), tet(T) 





(Table modified from 9) 
Table 2. Indicates the distribution 
of tel genes associated with efflux 













(Table modified from 9) 
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These genes belong to the major facilitator superfamily (MFS) and each code for an 
approximately 46 kDa membrane bound protein, and in gram negative bacteria are 
usually associated with large plasmids. In gram-negative bacteria, two genes 
establish the efflux system, o.ne coding the efflux protein itself and one coding for a 
repressor. Both are regulated by tetracycline. A chromosomally encoded tetracycline 
efflux system in E. coli is associated with multiple drug resistance. Nine ribosomal 
protection genes have also been characterized. Generally, these 72 kDa cytoplasmic 
proteins confer resistance to more tetracyclines than do the efflux proteins. 
Doxycycline resistance is commonly observed due to ribosomal protection. 
Resistance due to enzymatic alteration of the drug is by the action of the tet(X) gene 
product. Tet(U) confers low level resistance to tetracycline by an unknown 
mechanism (9). 
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1vfobilization a/Resistance Genes 
Although mutation has contributed to the resistance observed today and was 
possibly the initial step leading to the high level of resistance observed, HGT is 
thought to play the major role in the dissemination of antibiotic resistance genes. 
When such resistance genes become assembled within mobile genetic elements they 
generate multiple drug resistant clusters. Thus, genetic elements such as plasmids, 
transposons, and integrons can serve as vehicles by which the clustered resistance 
genes are transferred (21 ). 
HGT occurs by three mechanisms, conjugation, transformation and 
transduction. Conjugation involves direct contact between two living bacterial cells. 
Not all species are capable of conjugation. In E. coli the contact is mediated by a sex 
pilus, which acts as a conduit through which donor DNA can be transferred to the 
recipient. The DNA can be of chromosomal·or plasmid origin and the amount of 
DNA transferred depends upon the amount of time the cells are in contact. 
Transformation involves the uptake of DNA from the environment by a 
competent recipient cell. When bacterial cells lyse they release their contents into the 
environment and certain bacteria can take up the existing DNA fragments. The 
recipient cell can incorporate the DNA into their chromosome or plasmid via 
recombination. 
Transduction is mediated by bacteriophages. During a bacteriophage 
infection, the viral DNA is integrated into the bacterial hosts' chromosome. When 
·the virus replicates and packages its DNA, it can replicate and package portions of the 
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hosts' DNA. Thus, upon infection with the new viral particles, the bacterial host cell 
can acquire foreign bacterial DNA. 
Transfer of resistance genes via a plasmid was first described in 1959 when 
plasmid based resistance genes found in Shigella were transfen-ed to E. coli. 
Plasmids are self-replicating, circular pieces of DNA and are genernlly smaller than 
the bacterial genome. 
However, there is a limited range of bacteria in which plasmid transfer can 
occur. Because transposons and integrons are not limited by such ban-iers, they play 
a significant role in the transfer ofresistance genes (15). 
There are two types of transposable elements, insertion sequences (IS) and 
transposons. Insertion sequences are small mobile genetic elements that contain only 
the genes that encode for mobilization and have inverted terminal repeats. 
Transposons contain, in addition to genes for mobilization, other genes such as 
antibiotic resistant determinants. Transposons can be divided into two groups, group 
I involve an RNA intermec.liate (reverse transcriptase), and group II are comprised of 
those elements with a DNA intermediate. Group II transposable elements (TE) are 
characterized by the presence of inverted terminal repeats (T!Rs) and the presence of 
a transposase gene (31 ). Transposons of most bacteria can also be divided into four 
classes. Class .1 transposons are composed of insertion sequences and related 
composite transposons (17). These transposons are relatively large, complex, and 
have !S's, usually as inverted repeats, at their ends. Common members of this group 
are Tn 5, which confers kanomycin resistance, and Tnl 0, confers tetracycline 
resistance. The second class oftransposons consists of the TnA family. Although 
they lack a terminal IS, they have longer inverted terminal repeats than the class I 
transposons. The TnA members Tn3 and Tnl 000 are associated with ampicillin 
resistance. The third class consists of temperate phages, such as bacteriophage Mu. 
In this case, the entire phage acts as a transposon. The fourth class consists of large 
conjugative transposons. In this case the transposon can be transmitted via 
conjugation to a recipient cell. Tn917 is the representative transposon of this class 
and confers tetracycline resistance (17). 
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The process by which these genetic elements are excised from one genetic 
location and inserted into another is referred to as transposition. Transposons differ 
in their stringency of the insertion target sequence; some can insert randomly while 
others recognize more specific sequences. Two types of transposition are recognized, 
replicative vs. nonreplicative transposition. If the transposon is replicated at the 
donor site and a copy is inserted into the target site, it is replicative transposition. 
Nonreplicative transposition occurs when the transposon is excised from the donor 
site and inserted into the target site. Transposition differs from site-specific 
recombination in that a target sequence segment is duplicated and in that transposition 
can involve a variety of different target sequences for a single donor sequence (16). 
When resistance genes are associated with transposons and/or integrons they 
can be transferred from one plasmid to another or directly to the genome (15). 
Maze! and Davis report that integrons represent the most common mechanism by 




Integrons are potentially mobile, genetic elements that mediate the capture, 
mobilization and expression of gene cassettes. They contain a site-specific 
recombinase gene, an integron specific integrase gene termed inti. They also possess 
a specific recombination site or attachment site, termed aft 1 Gene cassettes are 
integrated via a site specific recombination event between the integron attl site and 
the attC site on the gene cassette. These gene cassettes often encode antibiotic and 
antiseptic/disinfectant resistance detenninants. Table 3 shows gene cassettes found in 
integrons that are often associated with antibiotic resistance. 
Gene cassettes are mobile genetic elements that can exist as circular non-
replicating DNA molecules. However, they typically exist as linear sequences that 
are part of larger genetic elements, such as plasmids or bacterial chromosomes. Gene 
cassettes normally consist of a single gene adjacent to a short sequence termed the 59 
base element (59be) or attC site and are generally between 500-1000 bp in length (6, 
36). The 59-be is highly variably in terms of sequence_ and length but it does possess 
a core site, GTTRRY, located at the right end (5' end), and an inverse core site, 
RYYYAAC, at the left end (3' end), which are important in recombination. An 
imperfect inverted repeat is found within the central region of the 59-be. The attC 
site is typically between 57 to 141 base pairs (17). 
19 
No palindromic structures are observed in the all I site because it does not 
contain an inverse core site. They are integrated via a site-specific recombination 
event between the integron attl site and a/IC site on the gene cassette: Cassettes 
appear to be excised in a circular form and integrated at the core sites, GTTRRRY, 
with crossover between the G and the first T. Short, specific DNA sequences with 
limited homology are required for site-specific recombination. It also appears to 
involve the formation of a Holliday junction intennediate and is a conservative 
process in which the breakage and rejoining of the DNA strands is accomplished with 
out utilization of ATP or DNA synthesis. This event is thought to be mediated solely 
by the integron encoded integrase. The integration/excision system for integons is 
unique in that it allows the insertion of multiple gene cassettes into a single attl site 
(17). 
Integron integrase belongs to a larger group of tyrosine recombinases (site 
specific recombinases) that is generally divided into two families, the resolvase 
family and the integrase family. Features of the integrase family include several 
conserved motifs, two conserved regions termed box I and box 2 located at the 
carboxyl terminal, and three shorter conserved regions, patch I, II, and III, located 
near box I. Patch I, II, and III are thought to play a role in the formation of the 
secondary structure of the protein. The box I and box 2 region contains the 
conserved amino acid residues RHRY. Studies have indicated that substitution of the 
arginine residues with non-positively charged amino acids abolishes substrate 
recognition, while mutation in the conserved tyrosine results in the inability to 
catalyz_e recombination. Integron integrase contains an additional 35 amino acids 
near patch III that is not found in other members of the family. Although the exact 
function of this additional region is not 
Table 3. Gene cassettes encoding antibio_tic resistance genes in integrons 
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known, it is speculated that it plays a role in recognition and binding of the at/I and 
at/C sites during recombition (36). 
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Integrons are very similar to lambda integration and excision into/out of the E. 
coli chromosome, except integrons use the same enzyme to mediate both reaction and 
gene cassettes do not replicate as independent DNA molecules (6). 
Four classes ofintegrons, each of which are distinguished by a distinct but related 
integrase enzyme, have been identified thus far (27, 36). The alt] site also differs in 
each class. The four- integron integrases exhibit 45-60% sequence identity (17). 
Class 1 integrons are the most common and are especially common among the 
gram negative Enterobacteriaceace (22, 27). The basic integron structure, designated 
In 0, is a class 1 integron that lacks a variable region, or integrated gene cassette ( 6). 
Characteristics of class integrons (figure 4) include a 5'·conserved segment, 
that contains a promoter region from which the integrated genes are expressed, and 
the at/11 site. A 25-bp sequence (lri) is found at the outer end of the 5' CS and also 
as an inverted repeat (IRt) at the other end of the integron (25). Most class l _ 
integrons also possess a 3' conserved region as well. This region typically consists of 
a truncated version of the quaternary ammonium resistance gene, qacEL11, and a 
sulfonamide resistance gene, sull 1. In addition, two open reading frames designated 
or/ 5 and otf 6 of unknown function have been identified. A variable region, within 
which the gene cassettes are found, is located between the 5' and 3' conserved region. 
Class I integrons are the most common class found in both clinical and 
environmental multi-drug resistant isolates. Class I integrons have now also been 
identified in many of the early multi-drug resistant plasmids. 
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Tn21, and pSa, both isolated from Japan, and plasmids R46, R751, Rl033, 
and R388 isolated from Europe in the l 960's and early 70's all contain class I 
integrons. It has thus been suggested that class I integrons were widely distributed 
among bacterial populations prior to the widespread use of antibiotics in human (25). 
Class 2 integrons are associated with Tn7, lack the 3 conserved region 
associated with class 1 integrons, and typically possess three gene cassettes (6, 12). 
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Figure 4. Class I integron structure. The 5' conserved region consists of the integron 
integrase gene and the attl site. The variable region contains the attc site and 
associated gene cassettes. This region varies in terms oflength depending upon the 
number of inserted cassettes. Most Class I integrons also possess a 3' conserved 
region containing an antiseptic resistance gene (qacLI E 1) and gene conferring 
sulfonamide resistance (sul I ) as well as two opening reading frames of unknown 
function. Promoters are represented by arrows. Gene cassettes are expressed from 
an integron promoter designated Pan1- (Figure modified from 12) 
adenylytransferase, inactivates streptomycin, and the d_fi·AJ gene product, a 
dihydrofolate reductase enzyme, confers trimethoprim resistance (14). Little 
variation is observed among the gene cassettes _of class 2 integrons because the 
integrase gene, inti 2, has a point mutation that has resulted in an internal stop codon. 
Thus, the truncated polypeptide is not capable of incorporating new gene cassettes or 
excising existing cassettes. However, Tn 1825 and Tn 1826 contain class 2 integrons 
that exhibit a variation of the cassette observed in Tn7. This could be contributed to 
intJJ rather than int12. Many isolates have been described as containing both class 1 
and class 2 integrons. It appears that the class 1 integrase exhibits broader specificity 
than does the class 2 integrase. Although recombination is more efficient between the 
attJJ sites, JntJJ can mediate recombination between the attl 1 site as well as the at/12 
sit. (15). 
Class 3 integrons have only been described in Serratia marcesenes and 
although they appear not to be as common as class 1 and 2 integrons they are 
associated with antibiotic resistance. Class 4 integrons are found only in Vibrio 
species, mainly Vibrio cholera, and are not generally associated with antibiotic 
resistance genes. 
It is important to note however, that simply acquiring these antibiotic 
resistance genes does not confer an advantage to those isolates possessing them. The 
genes must be coordinately regulated and expressed and the population containing 
them selected. Because the gene cassettes Jack promoters they are expressed from the 
promoter region located in the 5' CS region of the integrons. Two potential promoters 
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have been identified in class I integrons, Pl and P2. The Pl promoters can be fmiher 
divided into strong, weak, and hybrid; whereas the P2 promoters are divided into 
active and inactive (32). However, Peters, et al., identified coding sequences and 
ribosome binding sites in front of the ereA gene cassette of an Enterobacteriaceae 
urinary isolate that suggests the cassette can be transcribed from its own promoter 
sequence as well as the promoters in the 5' integron region (27). Schmitz, et al., 
looked specifically at five enterobacterial species and analyzed changes in the 
integron type and associated promoter structure as well as gene cassette size over a 7-
year period (32). Nine hundred isolates were obtained from blood cultures of patients 
at the University Hospital Dusseldorfin 1993, 1996, and 1999. For each year, the 
first 200 E. coli species and first 25 of each species of Klebsiella pneumonia, 
Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes were analyzed 
to determine the presence of class 1 integrons, and the size of the inserted DNA was 
assessed. In those isolates containing class 1 integrons, the 5' CS promoter region 
was also sequenced. Eight hundred and forty one isolates of the 900 were shown to 
not be clonally identical and carried integron structures. A significant increase was 
observed in the prevalence ofintegrons with time; 13 of276 in 1993, 27 of278 in 
1996, and 50 of287 in 1999. OftheK. oxytoca species, 26.8% possessed integrons, 
6.3% of the E. coli, 10.6% of the K. pneumonia, 21.9% of the E. cloacae, and 19.7% 
of the E. aerogenes isolates were integron positive. In addition, there was also an 
observed increase in gene cassette size with time; 650 to 1800 bp in 1993, and 750 to 
3000 in 1999. A shift in the promoter distribution was observed among the isolates in 
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this study. The percentage of high efficiency transcriptional promoters increased 
from 23.1% in 1993 to 33.3% in 1996. to 60% in 1999. These promoters include Pl 
strong and P 1 weak plus P2 active. Empty integron structures, containing no inserted 
gene cassette, were found in seven of the isolates (32). 
Integrons are located on unrelated plasmids, in association with transposons, 
or on bacterial chromosomes (25). This could indicate that they have been mobile in 
the past and have moved via transposition to the various sites they are now found. 
One class 1 integron identified by sequence analysis, Tn402, is known to be an active 
transposon. However, other integrons described appear to be transposition defective 
derivatives of a Tn402 like ancestor (6). 
Integrons themselves are not mobile; they can however, mobilize different 
gene cassettes. In addition, class 1 and 2 integrons are commonly associated with 
transposons, many of which are found on conjugative plasmids. Thus, integrons have 
a potential crucial role in the HGT of bacterial genes, particularly antibiotic resistance 
genes and therefore make an important contribution in the dissemination of multiple 
drug resistance (I 8). 
Although integrons have only recently described as distinct genetic elements 
associated with antibiotic resistance, they were present on many of the earliest 
multidrug resistant plasmids (6). Plasmid NRl, the source ofTn21, and pSa were 
both isolated in Japan in late 1950's and 1968 respectively, both contained class 1 
integrons. In addition, plasmids R46 and 751, 1033, 388, isolated from resistant 
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strains in Europe in the l 960's and early l 970's also contained a class 1 integron 
(28). 
It is speculated that integrons are transposition defective transposon derivates, 
i.e. transposons that have lost their tni genes and thus the ability to be mobile. In fact 
one integron designated Tn 402, still possess all the tni genes and is thus an active 
transposon. The ancestor to integrons is thought to be Tn 21 or a Tn 21 like 
transposon, which has lost the ability to transpose when an IS interrupted the tni. 
genes. 
Class 1 integrons that contain the 3' CS could have arisen from an ancestor 
resembling Tn402 by incorporating the quacE~l, sull genes as well as orf5 and 6. In 
fact, the qacE gene exists as a gene cassette. The class I integons that contain the 3' 
CS have lost the tni genes, and are defective in self-transposition. In addition, many 
have lost all or most of the 23 84 bp 3' CS as well. 
One group of class I integrons, designated the In5 type, have been identified 
as containing IS1326, and have lost parts of the 3' CS and tni genes. Other members 
of the group have also lost the !SJ 326. 
Antibiotic Resistance in clinical And Environmental isolates 
' A number of studies have described and characterized the integrons present in 
clinical isolates and a few have examined environmental isolates for integrons. 
White, et al, (2001) recently conducted a study in which they determined the 
presence and class of integrons in a collection of one hundred and twenty urinary 
isolates, belonging to the Enterobacteriaceae, collected from nine clinical settings in 
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Sydney: Australia (39). The organisms were identified as Escherichia coli, Proteus 
sp., Enterobacter sp., and Klebsiel/a sp. Antibiotic susceptibility tests were 
conducted on the isolates using a panel of 18 antibiotics, representing I I classes. 
Eighty-one percent of the isolates (79 of the 120 isolates) exhibited resistance to one 
or more antibiotic. Integrons were detected using PCR with primers, which hybridize 
to the conserved regions of the integrase genes intJJ, inf 12, and inti 3. 
Forty-nine percent (59 of the 120 isolates) were positive for integrons. The 
specific class of integron was then determined by digesting the integrase PCR 
products with Rsal or Hin.fl restriction enzymes and analyzing by restriction fragment 
length polymorphism (RFLP). Thirty-six percent contained a single class I integron, 
while 3% contained two class I integrons. In addition. 6% contained class I and 2 
integrons, and 4% contained a class 2 integrons. No class 3 integrons were detected. 
Eleven different cassette arrays were identificu in the class I integrons and overall 
there was a significant association between the integrun, anu resistance to 
gentamicin, kanomycin, streptomycin, tobramycin. sulfafura,ole. trimethoprim, 
ampicillin chloramphenicol, and tetracycline. Ho11 c, er. resistance uirectly related to 
integrons, include only gentamicin, kanomycin. tohramycin. sulfafurazole, 
trimethoprim, and streptomycin. (39) 
Peters et al, also indicate an increase of multiresistant Enlerohacteriaceace 
during 1995-1996 at the University Medical Center Utrecht (Netherlands) (2001). 
The presence of class I integrons was demonstrated by PCR in 35 of 68 multi-drug 
resistant Enterobacteriaceace. 
Another recent study also analyzed the presence of class 1 integnins and the 
associated gene cassettes in E. coli isolates from Kaohsiung, Taiwan. Fifty-four of 
the 104 clinical isolates were positive for class 1 integrons (8). Thus, this and the 
previous studies indicate the wide spread presence and antibiotic contribntion of 
integrons in clinical isolates. 
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In fact, most studies have dealt primarily with integron imparted resistance, 
specifically class 1 integrons, in clinical rather than environmental isolates. Rosser et 
al, however, has conducted a study charactering class 1 integrons in gram negative 
bacteria from an aquatic habitat. The results indicated that only 3.6% of the isolates 
contained the in/II gene. This tends to suggest that class 1 integrons are found in 
significantly lower numbers in natural environments than in clinical isolates. It is 
imp9rtant to note that less than 1 % of bacteria in environmental isolates is thought to 
be culturalable. In addition, the small population studied here was confined to only 
those bacteria that could be recovered on solid agar medium (34). 
The Triplett Creek Watershed 
Triplett Creek is located in Rowan County; Kentucky, and is the county's 
main tributary (Figure 5). Triplett Creek, along with its tributaries, drains 
approximately 1 00mi2 of Rowan County. Drainage is from· the ridge at the east of the 
county to the west toward the Licking River. 
The topography of the county is hilly to mountainous. It is located in the 
Knobs Region, which consists mainly of a band of rounded hills that border the 
Bluegrass. Shale with some sandstones and limestones of the Devonian to Early 
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Pennsylvani,m age, predominate in the Knobs region: Soils associated with the creek 
mainly consist of siltstones, sandstone, and silt deposits. 
A large area of the county is part of the Daniel Boone National Forest and 
hardwood forests cover much of the watershed area. Siltstone and shale deposits are 
the major soil components. Land use consists mainly of small residential 
communities and some small rural farm communities were the major crop is corn or 
tobacco. Much of the bottomland exists as pasture with some cattle grazing. 
Industrial or commercial property includes the Morehead State University golf course 
and two saw mills located along the main stem of Triplett Creek. 
The watershed has a history of sewage contamination via straight-line pipes 
and failed or inadequate sewage treatment systems in the rural areas. Past studies 
have indicated high levels of fecal coliforms in the watershed and fecal coliform to 
fecal streptococci ratios have indicated a predominance of human fecal 
contamination. 
Objectives 
The objectives of this study are as follows: 
• To determine the density of coliform, fecal coliform, and fecal 
streptococci bacteria in the Triplett Creek water shed. 
• To evaluate the source of contamination by generating fecal coliform: 
fecal streptococci ratios. 
• To access the antibiotic resistance of selected fecal coliform isolates. 
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• To use polymerase chain reaction (PCR) to detect the presence of 
integrons, a potentially mobile genetic element often associated with 
multi drug resistance in enteric bacteria in the fecal coliform isolates. 
Significance 
The fecal coliform isolates were tested against a panel of antibiotics to 
generate resistance profiles. Antibiotics representing seven antibiotic classes, the 
macrolides, aminoglycosides, fluroquinoles, penicillins, cephalosporins, sulfonamide, 
and the Tetracyclines, were studied. Because members of these antibiotic classes are 
commonly used in a clinical setting it is common to observe organisms exhibiting 
resistance. 
Assessing the presence of fecal coliforms in the watershed can provide 
important information about the quality of the water by indicating the presence of 
fecal contamination and thus possibly the presence of potentially harmful pathogens. 
Although fecal coliforms are rarely pathogenic in healthy individuals, they are 
commonly associated with antibiotic resistance genes that are often located on 
plasmids or other mobile genetic elements. Thus they can serve as a vast reservoir for 
resistance genes, and because they can co-exist in the intestinal tract with potential 
pathogens they can transfer the resistance genes to those pathogens, creating a serious 
health concern. 
Integrons are genetic elements that are commonly associated with multi 
drug resistance in enteric bacteria in clinical isolates. However, few studies have 
looked at the role integrons might play in the transfer of resistance in environmental 
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isolates. Therefore, it is important to evaluate the presence of antibiotic resistance in 
environmental isolates as well as access the isolates for the presence of integrons. 
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Figure 5. Map of Rowan County Kentucky. The Red line indicates the main stem of 
Triplett Creek. The top right yellow line shows Christy Creek and the bottom yellow 
line indicates North Fork of Triplett Creek. The left yellow line highlights Dry 
Creek. As indicated by the map, nearly two-thirds of the county is drained by Triplett 
Creek. Common sample sites are indicated by green circles. 
' 
J 
Materials and Methods 
Site Description 
Water samples were collected at twenty-four sites along the Triplett Creek 
watershed. Table 4 indicates the sample sites, their designated number and OPS 
coordinates. A map of Rowan County Kentucky, indicating the watershed and 
sample sites, is shown in figure 5. Native trees and vegetation were associated with 
all sites sampled. In addition, Japanese knotweed was also found at several of the 
sites. 
Co/lectio11 of H20 Samples 
Water samples were collected at various times during 2001, 2002, and 2003 at 
the twenty-four sites studied (Table 5). Two 100-mL samples were collected in 
Whirl-pak sample bags (Nasco) from each site and stored on ice for transport back to 
the lab. All samples were processed within eight hours of collection. 
Bacteriological Analysis 
An aliquot of water, typically 10-15 mL for total and fecal coliforms, and 25 
mL for fecal streptococci, from each site was filtered by aspiration through a 0.45µm 
pore size membrane filter (Millipore Corp) (1, 2, and 3). Filters were transferred to 
selective/differential media and bacterial counts were determined after appropriate 
incubation. See Table 6 for media and incubation conditions. 
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Antibiotic Susceptibility Analysis 
Three isolated colonies were selected from each of the m-FC plate cultures 
and streaked onto tryptic soy agar (TSA; Difeo) plates to generate pure cultures. The 
TSA plates were incubated 35 °C for 24 hours. The isolates were assessed for 
resistance to a panel of antibiotics using the Kirby-Bauer (KB) agar diffusion method 
(5). Five mL Mueller-Hinton broths (MH; Difeo) were inoculated with the isolates 
and incubated in the shaking incubator at 35° C for 4 hours. This is equivalent to a 
0.5 Macfarland standard, approximately 1 to 2 x 108CFU/mL. Kirby Bauer (KB; 
Difeo) plates were streaked for confluency with the Mueller-Hinton broth cultures. 
The antimicrobial susceptibility test discs (BBL) were dispensed, using the BBL 
dispenser, onto the Kirby Bauer plates within 15 minutes of inoculation. Table 7 
indicates the antibiotics used. KB plates were incubated at 37 °C for 18-24 hours, 
after which the zone of inhibitions were measured and compared to published values 
to determine resistance, sensitivity, or intermediate resistance according to the 
National Committee of Clinical Laboratory Standarps (NCCLS). 
TABLE 4. Description of Sample Sites. 
Site#' Site 
TC-01 Haldeman Fire Station 
TC-02 MSU Golf Course 
TC-03 Steven's Used Cars 
TC-04 Mabry's 
CC-0 I 3 3 I 7 Christy Creek 
CC-02 Brinegar 





















Down stream of the confluence with Little Perry 
Creek behind Haldman /Hayes Crossing. Water 
typically flows at very low leve. Is mined for 
creek rock. Bed composed mainly of cobble 
substrate. Mostly native trees and vegetation, 
knotweed present. Old truck on bank. 
Up stream of bridge at MSU golf course. 
Water typically flows at very low level. Is 
mined for creek rock. Flat slate bed. Native 
trees and vegetation sloping banks. 
Stream wide. shallow. Sandy bed with some 
cobble substrate. Native trees and vegetation. 
Deer pool. slo\\ llowing. Steep banks with 
nati\'L' trccs and \'cgetation. Knotweed present. 
Also old car an<l truck on bank, partially 
suhmL·rg.c:J. 
Stn:mn narnm. !->ha Ihm. Rocky bed with native 
tn:t:!'> anJ \ 1..';..!t.'lallon forming a canopy over 
stream. ~c..·\ cral 1.Ta~ lish present. 
Shallo\\ stream. Cobble be<l with native trees 
and vc:gctat ion. ~not\\ t:c<l present. 
Rocky substrate. Native trees and vegetation. 
Very shallow steam. Flat shale bed. Moderate 
flow. Native vegetation and trees. 
"Tc, Triplet Creek; CC, Christy Creek; DC, Dry Creek; NF, North Fork of Triplett 
Creek; BB, Big Brush Creek; EB, Evans Branch. 
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Table 4. Continued. Desription of Sample sites. 
Site#" Site 





CC-06 SAE Fraternity House 38°11'01 "N 
83°20129 11 W 
CC-07 Tackett Road Bridge 
CC-08 
TC-05 Tolliver Road Bridge 
EB-03 MSU Parking Lot 











TC-07 Old Water Pump Station 38ol0'02"N 
83o26'24"W 
DC-01 Nichols Branch Bridge 38o09'49"N 





Cobble bed. Native vegetation and trees. 
Mostly flat bed, some cobble. Native vegetation 
and trees. Stream wide and shallow. Fish 
observed in sample area. 
Cobble bed. Shallow stream. Native vegetation 
and trees. 
Flat slate bed, shallow, slow flowing. Normal 
vegetation and trees, some knotweed present. 
Shallow, slow flowing. Mowed banks. 
Broken rock bed. Willow and native vegetation a 
and trees. Abundance of knotweed. Fish also 
observed in sample area. 
Smooth Rock bed, shallow water fast flowing. 
Native vegetation and knotweed. 
Sample site adjacent to vacant lot with grasses. 
Shallow , with native vegetation and trees. 
Several young trees at waters edge. Fish 
observed in sample area. 
"Tc, Triplet Creek; CC, Christy Creek; DC, Dry Creek; NF, North Fork of Triplett 
Creek; BB, Big Brush Creek; EB, Evans Branch. 
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TABLE 4 continued. Description of Sample Sites. 
Site#" Site 
DC-03 KY 5 l 9 Bridge 
TC-08 Park"s Estates 
TC-09 Highway 60 bridge 
NF-01 Cross Creek Road 










83°25'34 11 W 
38°12'42"N 
83°28'1 l "W 
TC-10 Old 801 Bridge (Fanners) 38°08'54"N 
83°32'51"W 
Site Description 
Shallow, fast flowing. Rocky substrate. 
Knotweed and native vegetation and trees up to 
waters edge. 
Shallow, cobble bed. One bank is rocky ledge. 
Native vegetation and trees. 
Shallow, fast flow stream. Cobble bed, sandy 
bank with some cobble. Sample site under 
highway 60 bridge. Colony of swallows under 
bridge. Native vegetation and trees. 
Water deep, muddy. Sample site under old 801 
bridge. Native vegetation and trees, and 
knotweed. 
"Tc, Triplet Creek; CC, Christy Creek; DC, Dry Creek; NF, North Fork of Triplett 
Creek; BB;Big Brush Creek; EB, Evans Branch. 
37 
Table 5. Dates samples were collected at each collection site. 
Collection Date 
2001 2002 2003 
Collection Site' 8-8 8-22 9-23 2-13 6-26 11-?2 3-31 
TC-10 + + + + + + 
TC-09 + + + + + + 
TC-08 + + + + + + 
TC-07 + + + + + 
TC-06 + + + + + 
TC-05 + + + + + 
TC-04 + + + + + 
TC-03 + + + + + 
TC-02 + + + + + + 
TC-01 + + + + + 
CC-08 + + 
CC-07 + + + + + + 
CC-06 + 
CC-05 + 








DC-03 + + + + 
EB-03 + 
"TC, Triplet Creek; CC, Christy Creek; DC, Dry Creek; NF, North Fork of Triplett Creek; 
BB, Big Brush Creek; EB, Evans Branch. 
Table 6. Media and Incubation conditions for culture of isolates. 
Incubation Incubation 
Media Temperature Time 
M-FC 44.5°C 24 and 48 hours 
M-ENDO 35 °C 24 hours 
M-ENTEROCOCCUS 35 °C 24 hours 











































Isolate Jde11tificatio11 and Mai11tei,a11ce 
Cultures were maintained by storing cells at -70°C. Cells were grown 
overnight in 10 mL sterile tryptic soy broth (TSB) at 37°C. After incubation, the 
cultures were transferred to sterile 15 mL centrifuge tubes using sterile pipettes and 
centrifuged at 5000 RPM for IO minutes at 4 °C. The supernatant was discarded and 
cells resuspened in 800 µL of sterile ice cold TSB. The suspension was transferred 
to sterile 1.5 mL microcentrifuge tubes. 200 µL of sterile ice cold glycerol was 
transferred to the tubes. The tubes were then stored at -70°C. 
Isolates that were detennined to be Int I I positive were identified by 
inoculating eosin methylene blue agar plates and incubating overnight at 37°C. 
Isolates exhibiting coli-type growth were considered Escherichia coli. The 
presumptive identification was confirmed by inoculating an EC-MUG broth tube 
(Difeo), an indole deep tube (Difeo), an MR-VP broth tube (Difeo), and a Simmon' s 
Citrate agar slant (Difeo) and incubating for 48 hours at 37°C. 
Isolates not exhibiting typical coli type growth were evaluated using an API-
20E multiple test strip (bioM' erieux). These isolates typically exhibited aerogenes-
type growth, mucoid pink colonies with dark centers, or were non-lactose fermenters, 
colonies were colorless. MacConkey agar plates (Difeo) were inoculated with the 
non coli-type colonies and incubated for 24 hours at 3 7°C. A cell suspension, 
equilivent to a #3 MacFarland's nephelometer standard, was prepared in saline 
solution and used to inoculate the 20 wells of the API-20E test strip. The API's were 
incubated for I 8-24 hours at 37°C and then evaluated to generate a profile number 
that was used to identify the isolate by comparison to the Analytical Profile Index. 
Polymerase Chain Reaction 
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Primers recognizing the conserved region of the class I and class 2 integron integrase 
gene were obtained and used to identify the presence of integrons in the fecal 
coliform isolates. A 1: 1 dilution was prepared from each stock primer and stored at -
20°C (147.5 p moles). See Table 8 for primer sequences and expected product size. 
Each primer was diluted 1/100 (3.69 p moles) for polymerase chain reaction (PCR). 
Primers were mixed by vortexing briefly and 2.5 µL of forward and 2.5 µL ofreverse 
primer was added to a 0.5 mL PCR tube. Primers·were obtained from Integrated 
DNA Technologies. Figure 6 shows the class I integron structure and primer binding 
sites. Integrase gene intJJ sequence and the annealing sites for primers Intl-3 and Int 
A and Int Bare shown in Figure 7. 2.5 µL of template DNA for int! I and 1.25 µL 
template DNA for inti 2 was added to the PCR tube followed by 5.0 µL of sterile 
H2O. HotStar Taq Master Mix (Qiagen) was vortexed briefly to mix and 12.5 µL of 
Master Mix was added to the tube. HotStar Master Mix provides a final MgCb 
concentration of 1.5 mM and 200 µM of each dNTP. When using the thermal cycle~ 
without heated lid (Minicycler PTC-150, MJ Research) 25 µL of sterile mineral oil 
was added to the tube. This step was omitted when using the thermal cycler with 
heated lid (Gene Amp PCR System 2700, Applied Biosystems). Refer to Table 10 
for cycling program that was used. 
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Table 8_. Oligonucleotides for PCR analysis of class I and class II integrons. 
Primer Nuleotide Sequence Target Product 
Size 
Reference 
I IE GGAATTCCGAGGAAGGTGGGGATGACGT 16S rDNA 2°" ,, 
13B CGGGATCCCAGGCCCGGGAACGTATTCAC 
lntA ATCATCGTCGTAGAGACGTCGG Intl I 892 
lntB GTCAAGGTTCTGGACGAGTTGC 
Intl-3F CCTCCCGCACGATGATC Intl I 280 
lntl-3R TCCACGCATCGTCAGGC 
lnt2-l F CGGGATCCCGGACGGCATGCACGATTTGTA Intl 2 233 
Int2-IR GATGCCATCGCAAGTACGAG 
I 
Primers corresponding to I 6S rDNA were u~ed as a positive control ( citation) 
Eschericheria coli pDU 202, which contains a class I integron, and Eschericheria 
coli, Tn7, containing a class 2 integron. were also used as positive controls (courtesy 
of Dr. Maurer, University of Georgia). Negati\'e controls included in every PCR 
were target DNA with out primers and primers,, itlwut target DNA. 
Microbial DNA was obtained for PCR using I.~,-,_ Cio reagent (Pierce). TSA 
plates were inoculated with frozen cell stock and im:uhated m ernight at 37°C. A 
colony from each plate was picked up using a sterile pipette tip and resuspended in 5-
10 µL of Lys-N-Go reagent. Table 9 indicates the thermal cycle program used. 
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Figure 6. Class I integron strµcture and primer binding sites. Both Int A and Int 1-1 bind to 
the conserved region of inti 1. Primers Int A and Int B binding sites are shown by bold black 
arrows. Primers Int 1-3 binding sites are indicated by gray arrows. 
90 I ccgatggcct tcgcgcaggg gtagtgaatc cgccaggatt gacttgcgct gccctacctc 
961 tcactagtga ggggcggcag cgcatcaagc ggtgagcgca ctccggcacc gccaactttc 
I 02 I agcacatgcg tgtaaatcat cgtcgtagag acgtcggaat ggccgagcag atcctgcacg 
108 I gttcgaatgt cgtaaccgct gcggagcaag gccgtcgcga acgagtggcg gagggtgtgc 
1141 ggtgtggcgg gcttcgtgat gcctgcttgt tctacggcac gtttgaaggc gcgctgaaag 
I 20 I gtctggtcat acatgtgatg gcgacgcacg acaccgctcc gtggatcggt cgaatgcgtg 
1261 tgctgcgcaa aaacccagaa ccacggccag gaatgcccgg cgcgcggata cttccgctca 
1321 agggcgtcgg gaagcgcaac gccgctgcgg ccctcggcct ggtccttcag ccaccatgcc 
13 81 cgtgcacgcg acagctgctc gcgcaggctg ggtgccaagc tctcgggtaa catcaaggcc 
1441 cgatccttgg agcccttgc£ ctcccgcacg atgatcgtgc cgtgatcgaa atccagatcc 
150 I ttgacc.:gca gug:caaacc ctcaclgmc cgcargc:ccg ttccatai:ag aagctgggcg. 
1561 aacaaaccat gctc2.ccttc cauaaaaccu a!.!.dat~1c11aa ccft..:-ttcatc cugdgtca•JC -~~ .... .... ~c:-t- ... e ... i:::-
1621 a(:caccggca agcgccgcg~1 cggccgaggt cttccgatct cctgaagcca gggcagatcc 
1681 gtgca(agca Cl'tlgccgta gaagaacagc aaggccgcca atgcctgacg tgcgtggag 
174 I !!ccgaaacct tgcgctcgtt cgccagccag gacagaaatg cctcgacttc gctgctgccc 
180 I aaggttgccg ggtgacgcac accgtggaaa cggatgaagg cacgaaccca gtggacataa 
1861 gcctgttcgg ttcgtaaact gtaatgcaag tagcgtatgc gctcacgcaa ct2gtccaga 
I 921 accttgaccg aacgcagcgg tggtaacggc gcagtggcgg ttttcatggc ttgttatgac 
Figure 7. Class I integrase gene, intll gene sequence. Primer annealing sites are underlined. 
Int-1-3 primer binding sites are shown in black. Primers Int A Int B binding sites are shown 
in blue. Escherichia coli plasmid pAK33 integron In 111, complete sequence. ACCESSION 
A Y260546. (NCBI) 
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Table 9. Lys-N-Go conditions. 
Cvcle Temperature (°C) Time 
1 65 30 seconds 
2 8 30 seconds 
3 65 90 seconds 
4 97 180 seconds 
5 8 60 seconds 
6 65 180 seconds 
7 97 60 seconds 
8 65 60 seconds 
9 80 Hold 
To optimize PCR, magnesium concentrations were varied in control cells Tn7 
and PDU 202 as well as in a fecal coliform isolate from 1.5 to 3.0 mM. Hot Star Taq 
Master Mix provides a final concentration of 1.5 mMMgCh. To alter the 
concentration a stock solution of25 mMMgC)z was prepared. Table 11 indicates the 
volume of stock MgC)z added to obtain the final concentration indicated. A 
magnesium concentration of 1.5 mM appeared to give the best result. 
Template amount was also varied to optimize PCR for the class 2 integrons by 
using different aliquots ofLys-N-Go product. A template amount of 1.25 µL resulted 
in the absence of a smeared PCR product in most cases. However, because the 
amount of DNA was not quantified and that amount varied in each Lys-N-Go mixture 
the result varied. 
All samples were stored at -20°C until analysis. 
















52°C (Class I integron primers Jntll) 
50°C (Class 2 integron primers) 
12°c 
12°c 
Table 11. Magnesium chloride concentration 
Final Mg 2++ concentr~tion 1.5 










All PCR products were analyzed by gel electrophoresis on 1.25% agarose gel 
(Fisher Scientific). All gels were made using I .25 g of agarose in IX TBE (Tris-
Borate-EDTA). Five µL ofloading dye was added to each of the PCR tubes. 
Loading buffer contained IO µL of RN Aase per 500 µL ofloading buffer. In 
samples containing mineral oil the dye was added directly to the bottom ofth~ tube. 
IO µL of sample was loaded into the each well. Five µL of I 00 bp DNA ladder (New 
England Biolabs) was also loaded into one well in each gel. Gels were stained with 
I µg/mL of ethidium bromide for 15 minutes. After staining, gels were rinsed with 
H20, visualized on a UV transilluinator and photodocumented. 
Results 
Bacteriological Analysis 
Water samples were collected along the Triplett Creek watershed, during 
seven sampling periods. The samples were filtered and selective/differential media 
used to culture total coliforms (TC), fecal coliforms (FC), and fecal streptococci (FS). 
Tables 12- 18 summarize the bacterial counts as well as the FC: FS ratios 
obtained at each sample site for each sample period. The FC: FS ratio can be used to 
differentiate human fecal contamination from other warm-blooded animal fecal 
contamination. A ratio less than 0.7 indicates nonhuman fecal contamination, 
whereas a ratio greater than 4.0 indicates human fecal contamination. A ratio 
between 0. 7 and 4.0 can be indicative of a mix of human and animal fecal material (2, 
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3). As shown in Table 12, the FC: FS ratios for sites TC-9 and CC-7 in the August 8 
collection indicate a mix of human and animal fecal contamination. The other sites 
appear to have only non-human contamination. Nine of the twelve sites sampled on 
August 22. 2001 and one of the sites from the September sample period contained 
fecal colif01ms of both human and animal origin (Tables 13 and 14). One site, TC-6, 
also appeared to be of human origin (Table 14). Six of the eight sights from February 
13, 2002 had FC: FS ratios that indicated a mix of human and animal origin (Table 
15). In addition, one site from this sample period, TC-10, had a high FC: FS ratio 
indicating contamination of human origin. Five of the seven sites sampled in June 
2002 indicated a mix (Table 16) and 12 sites from November indicated a mix of 
human and animal fecal material, while one site, TC-03 appeared to be predominately 
of human origin (Table 17). Six sites from the March sample period contained fecal 
coliforms of both human and animal origin, and at least 3 sites appeared to be of 
human origin (Table 18). 
It is interesting to note that Rowan County experienced a six-week dry period 
prior to the September 23, 2002 collection period (Table 16), whereas the November 
23, 2003 collection followed a relatively wet period in the county (Table 17). When 
comparing the eight sites sampled during both periods bacterial counts appeared to be 
relatively low during the dry period and the FC: FS ratios indicated predominately 
animal fecal contamination. The FC: FS ratios of two sites however, TC-08 and TC-
09, indicated contamination of mixed human and animal origin. In addition, site TC-
06 had an FC: FS ratio of 10.0, indicating fecal contamination of human origin. · 
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Table I 2. Bacterial counts for August 8, 200 I colleciion period. 
CFU/mL 
Site# TC FC FS FC\FS* 
TC-01 1400 360 820 0.44 
TC-02 1120 340 500 0.68 
TC-03 520 60 200 0.30 
TC-04 1240 350 790 0.44 
TC-05 740 140 380 0.37 
TC-06 750 340 1300 0.26 
TC-07 980 260 390 0.67 
TC-08 860 130 780 0.17 
TC-09 590 170 190 0.89 
TC-IO 550 56 260 0.22 
CC-07 720 120 140 0.86 
DC-03 2100 216 I I 90 0.18 
TC, Total coliform, FC, Fecal coliform, FS, Fecal streptococci. 
*FC: FS ratio< 0.7 indicates animal fecal contamination. 
FC: FS ratio between 0.7 and 4.0 indicates a mix of human and animal 
fecal material. FC: FS ratio> 4.0 indicates contamination mainly 
human in origin. 
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Table 13. Bacterial counts for August 22, 2001 collection period. 
CE! IllllI 
Site# TC FC FS FC\FS* 
TC-01 1300 3100 2670 1.16 
TC-02 380 20 310 0.06 
TC-03 290 170 420 0.40 
TC-04 690 480 320 1.50 
TC-05" 560 210 390 0.54 
TC-06 610 190 90 2.11 
TC-07 480 310 230 1.35 
TC-08 300 220 270 0.81 
TC-09 630 3-10 220 1.55 
TC-10 410 201) 230 0.87 
CC-07 370 150 70 2.14 
DC-03 1050 l0011 =' ~() 1.89 
TC, Total coliform, FC, Fecal coliform. FS. Fecal streptococci. 
*FC: FS ratio < 0. 7 indicates animal fecal contamination. 
FC: FS ratio between 0.7 and 4.0 indicates a mix of human and animal 
fecal material. FC: FS ratio > 4.0 indicates contamination mainly 
human in origin. 
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Table 14. Bacterial counts for February 13, 2002 collection period. 
CFULmL 
Site# TC FC FS FC\FS* 
TC-01 310 20 8 2.50 
TC-02 0 20 12 1.67 
TC-04 90 20 8 2.50 
TC-08 210 70 24 2.92 
TC-09 1100 0 24 0.00 
TC-10 840 370 36 10.28 
CC-07 80 40 0 0.00 
DC-03 100 50 40 1.04 
TC, Total coliform, FC, Fecal coliform, FS, Fecal streptococci. 
*FC: FS ratio< 0.7 indicates animal fecal contamination. 
FC: FS ratio between 0.7 and 4.0 indicates a mix of human and animal 
fecal material. FC: FS ratio > 4.0 indicates contamination mainly 
human in origin. 
Table 15. Bacterial counts for June 26, 2002 collection period. 
CE! !Im! 
Site# TC FC FS FC\FS* 
CC-01 54 248 46 0.54 
CC-02 56 480 34 1.41 
CC-03 52 500 48 1.04 
CC-04 8 400 40 1.00 
CC-05 78 620 48 1.29 
CC-06 12 480 24 2.00 
CC-08 50 85 28 0.30 
TC, Total coliform, FC, Fecal coliform, FS, Fecal streptococci. 
*FC: FS ratio< 0.7 indicates animal fecal contamination. 
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FC: FS ratio between 0.7 and 4.0 indicates a mix of human and animal 
fecal material. FC: FS ratio> 4.0 indicates contamination mainly human . . . 
mongm. 
Table 16. Bacterial counts for September 23, 2002 collection period. 
CFU/mL 
Site# TC FC FS FC\FS* 
TC-02 340 72 230 0.31 
TC-03 72 284 0.25 
TC-05 224 8 12 0.67 
TC-06 324 140 14 10.0 
TC-07 368 52 114 0.45 
TC-08 164 106 84 1.26 
TC-09 620 288 330 0.87 
TC-10 164 40 124 0.32 
TC, Total coliform, FC, Fecal coliform, FS, Fecal streptococci. 
*FC: FS ratio < 0. 7 indicates animal fecal contamination. 
FC: FS ratio between 0.7 and 4.0 indicates a mix of human and animal 
fecal material. FC: FS ratio> 4.0 indicates contamination mainly 
human in origin. 
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Table 17. Bacterial counts for November 22, 2002 collection period. 
CFU/mL 
Site# TC FC FS FC\FS* 
TC-01 1520 400 155 2.58 
TC-02 2680 370 200 1.85 
TC-03 970 1320 240 5.50 
TC-04 500 250 405 0.62 
TC-05 1000 220 515 0.43 
TC-06 1200 420 715 0.59 
TC-07 520 370 420 0.88 
TC-08 600 160 340 0.47 
TC-09 600 160 340 0.47 
TC-10 380 3040 1085 2.80 
CC-04 1880 970 445 0.99 
CC-07 1240 440 445 2.18 
CC-08 830 460 455 I.OJ 
DC-02 300 140 70 2.00 
DC-03 220 190 115 1.65 
EC-03 69 160 370 0.43 
NF-01 690 490 265 1.85 
BB-03 1760 1760 455 3.87 
TC, Total coliform, FC, Fecal coliform, FS, Fecal streptococci. 
*FC: FS ratio< 0.7 inclicates animal fecal contamination. 
FC: FS ratio between 0. 7 and 4.0 indicates a mix of human and animal 
fecal material. FC: FS ratio> 4.0 indicates contamination mainly 
human in origin. 
Table 18. Bacterial counts for March 31, 2003 collection period. 
CEI!iw! 
Site# TC FC FS FC\FS* 
TC-02 100 0 8 0 
TC-03 170 10 12 0.83 
TC-05 290 140 36 3.90 
Rodburn 130 10 32 0.31 
TC-06 300 140 52 2.70 
TC-07 470 490 40 12.25 
TC-08 1200 170 48 3.54 
TC-09 1090 780 104 7.50 
TC-10 2680 1370 156 8.78 
TC, Total coliform, FC, Fecal coliform, FS, Fecal streptococci. 
*FC: FS ratio< 0.7 indicates animal fecal contamination. 
FC: FS ratio between 0.7 and 4.0 indicates a mix of human and animal 
fecal material. FC: FS ratio> 4.0 indicates contamination mainly 
human in origin. 
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Antibiotic Susceptibility Analysis 
Ninety-two of the 132 tested (68.7%) exhibited resistance to one or more 
antibiotics. Thirty-two (23. 9%) of the isolates were resistant to three or more 
antibiotics. Intermediate resistance was also observed in a number of the isolates. 
Tables 19-23 shows the resistance profiles for each sample period and Figures 8-12 
indicate the percent of isolates resistant or intermediately resistant to the antibiotics 
tested for each sample period. As Figure 8 shows for the February 2002 sample set, 
significant p -lactam resistance was observed with I 00% of the isolates exhibiting 
resistance to ampicillin and 87% resistant to carbenicillin (13% of isolates exhibited 
intermediate resistance to carbenicillin), 40% percent resistance to piperacillin ( 40% 
intermediate resistance to piperacillin) and 66% resistance to cefazolin. 
Tables 24-26 indicate the resistance patterns according to presumptive source. 
Multidrug resistance was defined in this study as resistance to two or more 
antibiotics. As Table 27 indicates 23.5% of the total isolates were resistant to two or 
more antibiotics. In addition, if the percent ofresistance is viewed in terms of 
presumptive source, there is a much higher percentage of multidrug resistance in 
those isolates taken from samples exhibiting contamination from a presumptive 
human source (66.7%) than those from presumptive animal source sites (6.1 %). 
Also, 20% of the isolates from presumptive human contaminated sites ~ere resistant 
to four classes of antibiotic whereas, none of the isolates from animal contaminated 
sites were resistant to more than three classes. Table 28 summarizes the percent of 
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total isolates tested as well as the percent of presumptive human, animal, and human 
and animal mix that were resistant or intermediately resistant for each antibiotic. 
According to the FC:FS ratios, 11.3% of the isolates are presumed to have originated 
from human fecal contamination. The ratios also indicate that 61. 7% of the isolates 
appear to be of mixed human and animal source, and 27.1% exhibited ratios 
indicative of animal source isolates. 
Erythromycin resistance was not addressed in Table 28 because it can be 
contributed to the intrinsic resistance of gram-negative bacteria to macrolides. A 
moderate level of resistance was also observed in the ~-lactam antibiotics, the 
cephalosporins and penicillins. Between the two cephalosporiri.s tested, a higher 
percentage of resistance (17.3%) and intl!rmediate resistance (I 0.5%) was observed 
for the first generation cephalosporin than the second generation (2.6% resistant and 
7.6% intermediate). Isolates exhibited a higher percentage oi'ampicillin resistance 
than other penicillins, with 30.1 % resistant and 18.8"" intermediately resistant. The 
isolates tested also exhibited a high percent or resist.me,· t ~-!.(," "l and intermediate 
resistance (46.38%) to the aminoglycoside, streptom~ein. 
Its inieresting to note that when comparing antihiotie resistance patterns to 
potential origin of fecal contamination (Table 28) there appears to be a correlation 
between presumptive human source ·isolates and resistance to aminoglycosides 
(streptomycin, kanomycin, amikacin), trimethoprim and cephalosporins. 
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Table 19. Antibiotic Resistance Profile for fecal coliform isolate from February 13, 2002. 
Antibiotics" 
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a streptomycin* (S) I Oµg , trimethoprim* (TMP) 5µg, erythromycin (E) ISµg," kanomycin 
(K) 30µg, ciprofloxacin (CIP) Sµg, tetracycline (TE) 30µg, ampicillin (AM) IOµg, cefazolin 
(C2) 30µg, carbencillin (CB) I OOµg, doxycycline (D) 30µg, piperacillin (PIP) I OOµg, . 
cefuroxime *(CXM) 30µg, amikacin (AN) 30µg. 
* Antibiotics not tested during the February 13, 2002 collection period. 
R, Resistant. S, Sensistive. I, intermediately resistant 
57 
Table 20. Antibiotic Resistance Profile for fecal colifo,m isolate from June 26, 2002. 
Antibiotics a 
Isolate S* TMP* E K AN D TE CZ CXM CIP PIP AM CB - R s s s s Os s s s s CC-01-2 R s s s s s s s s s D 
CC-01-3 R s s s s ~:"4 s s s s ,, • :s 
~ R s s s s s s s s s s 
CC-02-3 R s s s s s s s s Ds 
emm2- R s s s s s s s s s s 
!r• 'Is s s s s s s s s s 
CC-03-2 R s s s s s s s s s 
CC-03-3 R s s s s s s s 
CC-04-1 R s s s s s s s 
CC-04-2 R R s R R s s s 
CC-04-3 R s s s s s li' 1 ,,,~ ' ls 
CC-04-4 R s s R R ·S s s s s s 
CC-05-1 R s s s s s s s R 
CC-05-2 R s s s s s s s s s R 
CC-05-3 R s s s s R .s s '.i':;~ill'ii~lF 
CC-05-4 R · !1~,;ls s s s s s s R s 
CC-06-1 R s s s s s s s s ~ s 
CC-06-2 r;t,"l!s s s s s s s s s 
CC-06-3 R s s s s s s s s 
CC-07-1 R s s s s s s s s 
CC-08-1 R s s s s s s s s 
CC-08-2 R s s s s s s s s 
CC-08-3 1, .•.•. )Is s s s s s s s 
a 
streptomycin* (S) I0µg , trimethoprim* (TMP) 5µg, ery1hromycin (E) 15µg, kanomycin 
(K) 30µg, ciprofloxacin (CIP) 5µg, tetracycline (TE) 30µg, ampicillin (AM) 1 0µg, cefazolin 
(C2) 30µg, carbencillin (CB) 1 00µg, doxycycline (D) 30µg, piperacillin (PIP) 1 00µg, 
cefuroxime (CXM) 30µg, amikacin (AN) 30µg. 
* Antibiotics not tested during the June 26, 2002 collection period. 
R, Resistant. S, Sensistive. I, intermediately resistant. 
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Table 21. Antibiotic Resistance Profile for fecal coliform isolate from September 23, 2002. 
Antibiotics 
a 
Isolate S* TMP* E K AN D TE CZ CXM CIP PIP AM CB 
TC-8-1 R !M >j< I I: :4: i'.rj:1t1:::j Is ~·: '· : I TC-8-2 R s s s s s s s s . I 
TC-3-1 R s s s s s s s s s s 
TC-3-2 r, ~Is s s s s s s s s s 
TC-3-3 R s s s s s s s s s s 
TC-3-4 R s s s s s s s s s s 
TC-9-1 R s s s s s s s s ,~ :P TC-9-2 R s s s s s s s s 
~ 
 
TC-9-3 s s s s s s s s s s . 
TC-5-1 R s s s s s s s s s s 
TC-5-2 R R R R R R ""' :f. Is R R R 
TC-5-3 R s s s s s s s s s 
TC-5-4 R :s s R R ·s s s s 
6-1- R :s s s s s s s s 
6-2- R s s s s s s s s 
6-3- R s s s s s s s s 
7-1- !~ills s s s s s s s s s 
7-2- R ·s s s s Wl~~"liS s s s s 
7-3- R s s s s s s s s s s 
5-1- R R R R R s R R R 
5-2- s s ms . s s 
5-3- R R s R R R R R 
8-1- R s s s s s s s 
8-2- R s s s s s s s 
8-3- R s s s s s s s 
'streptomycin* (S)l0µg ,trimethoprim* (TMP) 5µg, erythromycin (E) 15µg, kanomycin (K) 
30µg, ciprofloxacin (CIP) 5µg, tetracycline (TE) 30µg, ampicillin (AM) I 0µg, cefazolin (C2) 
30µg, carbencillin (CB) I 00µg, doxycycline (D) 30µg, piperacillin (PIP) I 00µg, Cefuroxime 
(CXM) 30µg, amikacin (AN) 30µg. 
* Antibiotics not tested during the September 23, 2002 collection period. 
R, Resistant. S, Sensistive. I, intermediately resistant 
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Table 22. Antibiotic Resistance Profile for fecal colifom1s isolates from November 22, 2002 
Isolate S TMP E* 
CC-08-1 S S 
CC-08-2 1L 1S 
CC-08-3 S S 
CC-07-1 S S 
-1.s 
CC-07-3 iii · S p 
CC-04-1 :J S 
! 
CC-04-2 ii S 
DC-02-1 S S 
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s s s s 
s s s s 
s s s s 
s s s s 
s s s s 
s s s s 
s s s s 
s s s s 
'"",I,_.,..,,,,_ E:]s 
1
1 R S 
'.1 '';,:,:,.-,., ~'"""""--'-'' s s 
s s s s 
s s s s 
s s s s 
s s s s 
s s s s 
s s s s 
s s s s 
s s s s 
s s R s 
s s s s 
s s s s 
s s s s 
R R S S 
s s s s 
s s s s 
s s s s 
s s s s 
s s s s 


























































































































'streptomycin (S) I0µg , trimethoprim (TMP) 5µg, erythromycin* (E) 15µg, kanomycin (K) 
30µg, ciprofloxacin (CI) 5µg, tetracycline (TE) 30µg, ampicillin (AM) I0µg, cefazolin (Cz) 
30µg, carbencillin (CB) I 00µg, doxycycline (D) 30µg, piperacillin (PIP) I 00µg, cefuroxime 
(CXM) 30µg, amikacin (AN) 30µg. 
*Erythromycin not tested during the March 31, 2003 sample period. 
R, Resistant. S, Sensistive. I, intermediately resistant 
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Table 22 continued. Antibiotic Resistance Profile for fecal colifonns isolat~s from 
November 22. 2002. 
Antibiotic' 
Isolate s TMP E* K AN D TE CZ CXM CIP PIP AM CB 
TC-04-1 LJS s s s s s s s s s s 
TC-03-1 s R s s s s R J IS ii . IS s 
TC-03-2 R R s s s s R R .s ,L ••• ,, /R s 
TC-03-3 s R s s s s R it-:, :)l~s s s s 
TC-02-1 ;1<,,-,, Js s s [3s s s s s s s 
TC-02-2 s s s s s s s s s lli1.'~•:!R s 
TC-02-3 R s s s s s R s s s R s 
TC-01-1 R R s s s s s s s R R ·S 
TC-01-2 s s s s s s s s s R s 
TC-01-3 ~s . s s s s s s s -'.R s 
• streptomycin (S) I 0µg , trimethoprim (TMP) 5µg, erythromycin* (E) I 5µg, kanomycin (K) 
30µg, ciprofloxacin (CI) 5µg, tetracycline (TE) 30µg, ampicillin (AM) I0µg, cefazolin (Cz) 
30µg, carbencillin (CB) I 00µg, doxycycline (D) 30µg, piperacillin (PIP) I 00µg, cefuroxime 
(CXM) 30µg, amikacin (AN) 30µg. 
*Erythromycin not tested during the March 31, 2003 sample period. 
R, Resistant. S, Sensistive. I, intermediately resistant 
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Table 23. Antibiotic Resistance Profile for fecal coliform isolate from March 3 1, 2003. 
Antibiotics 
a 
Isolate s TMP E* K AN D TE CZ CXM CIP PIP AM CB 
TC-10-1 !1 is s s s s s s s s s s 
~R R Os s s R :1 1s R s s 
TC-10-3 R s s s s s R Us s R s 
TC-10-4 R s s s s s s s s r, JR s 
TC-9-1 R s l:C IR s s s s s s s s 
TC-9-2 hf;:Js s R s s ufu\.Js s R R s 
TC-8-1 s s s s R s s s s s s s 
TC-8-2 !1,]:t~s s s s s s s s s 11/ ~,0ls 
TC-8-3 R s s R R R s s s s R s 
TC-8-4 
~ 
s R s s s s s s :1 • .. ,;;js i~,~ s 
TC-7-1 l·<\•·S tc·••·-ls s s s s s s s s 
TC-7-2 1'f;lS s s s s s s s s s s 
TC-6-1 R ·s s s s s s s s s :1 t'.', 12·ls 
TC-6-2 s s s s s s .s s s s s s 
TC-5-1 s s s s s s s s s s i'~••f~is , __ ,, '"'"'{, 
TC-5-2 s s s s s s s s s s s s 
TC-5-3 s s s s s s s s s s s s 
TC-5-4 s s s s '1 . Is s s s s s s ~
3-1-Rod 'r'""~s s s s s I Is s R s Iv.:.;;, I 
3-2-Rod s s s s s s s s s s s s 
s s s s R 11 Is s R ·s 
TC-3-2 s R R - R s s s s s 
TC-2-1 s s s s s s s s 
TC-2-2 R s s .R R R s s s s 
"streptomycin (S) I0µg , trimethoprim (TMP) 5µg, ery1hromycin* (E) 15µg, kanomycin (K) 
30µg, ciprofloxacin (Cl) 5µg, tetracycline (TE) 30µg, ampicillin (AM) I 0µg, cefazohn (Cz) 
30µg, carbencillin (CB) I 00µg, doxycycline (D) 30µg, piperacillin (PIP) I 00µg, cefuroxime 
(CXM) 30µg, amikacin (A:N) 30µg. 
*Ery1hromycin not tested during the March 31, 2003 sample period. 
R, Resistant. S, Sensistive. I, intermediately resistant 
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E K 
Resistance for .02-13-2002 · 
D TE . CZ CIP PIP AM CB 
Antibiotics 
Figure 8. Percent of Fecal coliform i,olate, e,hihi1ing resistance or 
intermediate resistance to the.an1ihi,,1ie, 1e,1ed for 1he February 13, 2002 
collection period. 
Percent of Fecal Coliform Isolates Exhibiting Resistance or Intermediate 
















Figure 9. Percent of Fecal coliform isolates exhibiting resistance or 
intermediate resistance to the antibiotics tested for the June 26, 2002 
collection period. 
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Percent of Isolates 
II Resistant 
□ Intermediate 
Percent of Fecal Coliform Isolates Exhibiting Resistance or 









Figure 10. Percent of Fecal coliform isolates exhibiting resistance or 











Percent of Fecal Coliform Isolates Exhibiting Resistance or 
Intermediate Resistance for 11-22-02 
~~~ 
S TMP K AN D TE CZ CXM CIP PIP AM CB 
Antibiotics 
Figure 11. Percent of Fecal coliform isolates exhibiting resistance or 











II Resistanc 0 
□ lntennediate 
\ 
Percent of Fecal Coliform Isolates Exhibiting Resistance or 
Intermediate Resistance for 03- 31-2003 
S TMP E K AN D TE CZ CXM GIP PIP AM CB 
Antibiotics 
Figure 12. Percent of Fecal coliform isolates exhibiting resistance or 
intermediate resistance to the antibiotics tested for the March 31, 2003 
collection period. 
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Table 24. Antibiotic Resistance Profile of Fecal Coliform Isolates from a presumptive human source 
(FC:FS ratio greater than 4. 0) and identification of select isolates. 
Collection Date 
Isolate Organism a Antibiotic Resistance Profile 
Beta lactams 
66 
3-31-2003 Aminoglycosides Sulfonamide Cephalosporins Penicillins Tetracycline's Fluroquione 
TC-10-01 E. coli S(I) 
TC-10-02 Enterobac/er cloaca S, K(I) TMP CZ,CXM 
TC-10-03 E. coli s CZ, CXM(I) AM, PIP 
TC-10-04 Klebsiella pneumonia s AM, PIP 
TC-07-1 E.coli S(I) 
TC-07-2 E. coli S(I), K(I) 
TC-09-1 E. coli S, K(I), AN 
TC-09-2 E. coli S(I), AN CZ(!), AM, PIP 
9-23-2003 
TC-06-01 AN CZ,CXM AM,PIP,CB TE(]), D 
TC-06-02 AN CZ AM 
TC-06-03 K CZ,CXM PIP(l)CB(I) TE,D 
11-22-2002 
TC-03-01 K.lebsiel/a pneumonia TMP CZ, CXM(I) PIP(I) 
TC-03-02 s TMP CZ,CXM AM,PIP 
TC-03-03 Eschericha coli TMP CZ, CXM(I) 
2-13-2002* 
TC-10-01 K(J) AM,PIP,CB 
"Streptomycin (S) 1 0µg , Trimethoprim (TMP) Sµg, *Erythromycin (E) I Sµg, Kanomycin (K) 30µg, Ciprofloxacin 
(CI) Sftg, Tetracycline (TE) 30µg, Ampicillin (AM) I0µg, Cefazolin (Cz) 30µg, Carbencillin (CB) I00µg, 
Doxycycline (D) 30µg, Piperacillin (PIP) I 00µg, Cefuroxime (CXM) 30µg, Amikacin (AN) 30µg. 
*S and TMP not tested during this sample period. 
CIP 
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Table 25. Antibiotic Resistance Profile of Fecal coliform Isolates detennined to be from a presumptive 































Organism a Antibiotic Resistance Profile 
Beta lactams 














AM,PIP,CB TE ,D 






















"Streptomycin (S) I0µg , Trimethoprim (TMP) 5µg, *Erythromycin (E) l5µg, Kanomycin (K) 30µg, Ciprofloxacin 
(CI) 5µg, Tetracycline (TE) 30µg, Ampicillin (AM) I0µg, Cefazolin (C2) 30µg, Carbencillin (CB) I00µg, 
Doxycycline (D) 30ftg, Piperacillin (PIP) I00µg, Cefuroxime (CXM) 30µg, Amikacin (AN) 30µg. 





Table 25 continued. Antibiotic Resistance Profile of Fecal Colifom1 Isolates detem1ined to be from a 
Presumptive mix of Human and Animal origin (FC:FS rations 0. 7-4. 0). 
Collection Date 
Isolate Organism 'Antibiotic Resistance Profile 
Beta lactams 
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AM ,PIP TE(l),D(I) 
AM,PIP 
"Streptomycin (S) !Orig , Trimethoprim (TMP) 5µg, *Erythromycin (El ISµg, Kanomycin (K) 30µg, Ciprofloxacin 
(Cl) 5µg, Tetracycline (TE) 30µg, Ampicillin (AM) IOµg, Cefazolin (C2) 30µg, Carbencillin (CB) IOOµg, 
Doxycycline (D) 30µg, Piperacillin (PIP) IOOµg, Cefuroxime (CXM) 30r1g, Amikacin (AN) 30µg. 
*Sand TMP not tested during February and June 2002 sample periods. 
Table 25 continued. Antibiotic Resistance Profile of Fecal Coliform Isolates dete1111ined to be from a 
Presumptive mix of Human and Animal origin (FC:FS rations 0.7-4.0). 
Collection Date 
Isolate Organism 'Antibiotic Resistance Profile 
Beta lactams 
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TC-03-0 I Enterobacter cloaca 










































aStreptomycin (S) IOµg , Trimethoprim (TMP) 5µg, *Erythromycin (E) l 5µg, Kanomycin (K) 30µg, Ciprofloxacin 
(CI) 5µg, Tetracycline (TE) 30µg, Ampicillin (AM) I0µg, Cefazolin (C2) 3011g, Carbencillin (CB) I00µg, 
Doxycycline (D) 30µg, Piperacillin (PIP) I00µg, Cefuroxime (CXM) 30µg, Amikacin (AN) 30µg. 
*Sand TMP not tested.during February and June 2002 sample periods 
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Table 26. Antibiotic Resistance Profile of Fecal Coliform Isolates determined to be from presumptive animal source. 
(FC:FS ratio < 0. 7) 
Collection Date 
Isolate Organism • Antibiotic Resistance Profile 
Beta lactams 
Aminoglycosides Sulfonamide Cephalosporins Penicillins Tetracyclines Fluroquione 
2-13-2002 
CC-07-01 CZ AM,CB D 
CC-07-02 CZ AM,CB CIP 














TC-04-01 TMP(I) TE(I) 
9-23-2003* 
TC-08-01 K,AN CZ,CXM AM(l),PIP(I) TE(I), D(J) 





TC-05-01 K,AN CZ,CXM{J) AM,PIP,CB TE,D 
TC-05-02 
TC-05-03 
TC-05-04 AM(!) TE.D 
"Streptomycin (S) J0µg , Trimethoprim (TMP) 5µg, *Erythromycin (E) 15µg, Kanomycin (K) 30µg, Ciprofloxacin 
(CJ) 5µg, Tetracycline (TE) 30µg, Ampicillin (AM) JOµg, Cefazolin (C2) 30µg, Carbencillin (CB) JO0µg, 
Doxycycline (D) 30µg, Piperacillin (PIP) J00µg, Cefuroxime (CXM) 30µg, Amikacin (AN) 30r1g. 
*Sand TMP not tested during February and June 2002 sample periods 
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Table 26 continued. Antibiotic Resistance Profile of Fecal Colifom1 Isolates determined to be from presumptive 
animal source. (FC:FS ratio< 0.7) 
Collection Date 
Isolate Organism a Antibiotic Resistance Profile 
Beta lactams 









TC-04-01 E. coli CZ(l), CXM(I) AM 
TC-04-02 E. coli 
TC-02-01 E. coli AM(!) 
TC-02-02 E.coli AN AM(!) TE,D 
"Streptomycin (S) I0µg , Trimethoprim (TMP) Sµg, *Erythromycin (E) ISµg, Kanomycin (K) 30µg, Ciprofloxacin 
(Cl) Sµg, Tetracycline (TE) 30µg, Ampicillin (AM) IOµg, Cefazolin (C2) 30µg, Carbencillin (CB) I00µg, 
Doxycycline (D) 30µg, Piperacillin (PIP) I00µg, Cefuroxime (CXM) 30µg, Amikacin (AN}30ftg. 
*Sand TMP not tested during February and June 2002 sample periods 
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Table 27. Number ofmultidrug Resistant isolates. 
Isolates from Collection Sites Exhibiting Contamination From 
# Antibiotic Total# Isolates · Human Source Animal Source Human/ Animal Mix 
Classes (132) (15) (36) (82) 
¾R(#) %R (#) % R(#) % R(#) 
4 classes 3.03% (4) 20% (3) 0 2.78% (I) 
3 classes 6.82% (9) 20% (3) 3.66% (3) 8.33% (3) 
2 classes 13.64% (18) 26.2% (4) 2.44% (2) 35.56% (11) 
Total # of 
Multidrug 
Resistant 
Isolates 23.48% (31) · 66.67 % (I 0) 6.10% (5) 41.67% 
(15) 
Table 28. The percent resistance and percent intermediate resistance to the antibiotic class (antibiotics) tested for the total 
number of isolates tested as well as for those isolates of 12resum12tive human. animal. and a mix of human and animal origin. 
Isolates from presumptive Isolates from presumptive Isolates from presumptive 
Antibiotic Class Total# Isolates (133) Human source (15) Animal Source (36) Human/ Animal Mix (82) 
# Isolates # Isolates #Isolates # Isolates 
Antibiotic Tested ¾R %1 Tested ¾R %1 Tested %R %1 Tested ¾R 1% 
Aminoglycosidcs 
Streptomycin 69 24.6 46.38 II 63.64 36.36 13 30.77 46.15 44 18.18 47.73 
Kanomycin 133 3.76 10.53 15 13.33 26.67 36 2.78 0 82 2.44 12.20 
Amikacin 118 6.78 1.69 15 40.00 20.00 32 9.38 3.13 71 9.23 0 
Sulfonamide 
Trimethoprim 69 7.25 1.45 11 45.45 0 13 0 5.38 44 2.27 0 
Floroquione 
Ciprofloxin 33 3.78 1.5 15 13.33 0 36 5.56 0 82 2.44 0 
(Beta-Lactams) 
Cephalosporin 
Cefazolin (1st generation) 133 17.29 10.53 15 46.67 13.33 36 I I. I I 13.89 82 13.41 13.41 
Cefuroxime (2"' generation) 118 2.54 7.63 14 21.43 26.67 32 0 9.38 71 0 2.82 
Penicillins 
Ampicillin 133 30.1 18.8 15 40.00 6.67 36 22.22 I 9.44 82 30.49 9.76 
Piperacillin 133 10.53 12.03 15 20.00 33.33 36 13.89 2.78 82 10.98 13.41 
Carbenicillin 133 13.53 8.28 15 13.33 6.67 36 13.89 30.56 82 13.41 4.88 
Tetracycline 
Tetracycline 133 9.77 5.26 15 6.67 13.33 36 I I. I I 8.33 82 8.54 4.88 
Doxycycline 133 12.78 0.53 15 6.67 6.67 36 11.11 8.56 82 12.20 14.63 
R, Resistant. I, Intermediately resistant. 
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Polymerase Chain Reaction 
Primers corresponding to the conserved regions of the class I integrase gene, 
int II, and class 2 integrase gene, int/2, were used to detect the presence of class I and 
class 2 integrons in 126 of the fecal coliforms isolated from the Triplett Creek 
watershed. Nine of the 15 isolates from the February collection, and all of the 
isolates frome the June, September, November, and March collection periods were 
evaluated. Table 28 lists and describes the presumptive integron positve isolates. 
The nine February isolates and 24 June isolates were tested with Int 1-3 
forward and reverse primers. None of the isolates exhibited a product (gels not 
shown). Six of the June isolates, CC-08-3, CC-08-1, CC-04-3, CC-04-2, CC-02-3, 
and CC-02-2 exhibited the expected 280 base pair product (Figures 17, 18, and 19) 
(Table 27). However, isolates CC-08-3, CC-04-2 during the same PCR reaction, 
exhibited a larger band, 1080 bp and 1140 bp respectively, in addition to the desired 
product (Figure 17; Table 27). All six of the isolates produced product oflarger size 
during other PCR reactions. Four of the six isolates, CC-02-2, CC-04-2, CC-04-3, 
and CC-08-3 produced a product 310 bp in size (Figures 15 and 16; Table 27). Also 
with the exception of CC-08-3, the isolates previously mentioned produced a product 
' 
of 1100 bp in length (Figures 13 and 15; Table 27). With the exception of isolates 
CC02-2 and CC-04-3, these isolates produced larger product of various size during 
other PCR reactions (Figures 13, 15, and 16; Table 27). Many of the isolates did not 
exhibit any bands of280 base pairs, but did exhibit product(s) larger than 280 base 
pairs (Figures 13-20). In addition, the intll positive control cell exhibited a very 
faint band around 460 base pairs along with the expected 282 base pair fragment 
(Figures 13 and 20). 
For isolates that had previously exhibited product; the PCR was repeated 
using Int 1-3 forward and reverse primers, Int 1-3 forward only, and Int 1-3 reverse 
only primer. The June isolates not previously tested were also evaluated with the 
same primers. (Figures 15-20) 
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In two of the isolates, CC-03-2 and CC-03-3, the Int 1-3 reverse primer 
produced a product of approximately 1160 and 1140 base pairs, respectively (Figures 
17 and 18). The Int 1-3 reverse primer also produced a single product of 1130 base 
pairs in pDU 202 ( class I integron positive cell; Figure 21; Table 26) as well as a 
product of 1165 base pairs in Tn7, (class 2 integron positive cell; Figure·15; Table 
26). This is close in size to the 1100 bp,fragment observed in the potential positive 
isolates. 
CC-08-3 and CC-08-1 exhibited intermediate resistance to cefazolin and 
FC:FS ratios were indicative of contamination from potential animal source. CC-02-
2 and CC-02-3 did not exhibit resistance or intermediate resistance to any of the 
antibiotics. CC-04-3 exhibited intermediate resistance to both cefazolin and 
ampicillin, while CC-04-2 was resistant to doxycycline and tetracycline, kanomycin, 
and intermediately resistant to carbenicillin and ampicillin. All four isolates exhibited 
FC:FS ratios that indicated a presumptive mix of human and animal fecal 
contamination. Isolates from the June sample period have not yet been identified. 
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The 25 September isolates were evaluated using primers Int A and Int B. No 
bands were observed (gels not shown). 
The 24 isolates from the November sample period were tested for class I 
integron using Int A and Int B. One of the isolates, CC-07-2, did produce the 
expected 892 base pair product (Figure 22; Table 26). The isolate was identified as 
Escherichia coli and the sample from which it came had an FC:FS ratio indicative of 
a mix of human and animal contamination as the potential isolate source. The isolate 
did not exhibit resistance to any of the antibiotics tested but did exhibit intermediate 
resistance to streptomycin. 
The 24 March isolates were tested using Int 1-3 forward and reverse primers. 
Two of the isolates, TC-03-1 and TC-03.-2. exhibited the expected 282 base pair 
product and no additional product (Figure 22 ). TC-03-1 was identified as 
Enterobacter cloaca, and exhibited resistance lo stn:ptomycin. cefalozin, and 
ampicil!in and intermediate resistance to cefuroxime. Isolate TC-03-2 was resistant 
to streptomycin, cefalozin, ampicillin, and in1crmeJia1cl~ n:sistant lo cefuroxime. 
This isolate was identified as£. coli. Both isolutes \\ ere from the same site, which 
exhibited an FC: FS ratio indicative of a presumpth·e mix of human and animal 
ongm. 
Polymerase chain reaction was repeated on the presumptive positive June 
isolates, and the positive November and March isolates using primers Int A and Int B. 
However, multiple bands of various sizes were observed (Figures 24 and 25). 
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Isolates TCl-033103-003, CC 17, CCI I, CC8, CC7, and CC 5 produced in addition 
to products of other size, a band approximately 892 base pairs (Figures 24 and 25). 
Due to the variable results the PCR was repeated to check the reagents for 
contamination. The same master mix and primers were used. There were no 
observed bands or smears in the primer only lanes (no template added) and in the 
template only lanes (no primer added; gels not shown) 
. None of the isolates tested appeared to possess the intl2 gene. Thus, it is 
presumed that they did not contain a class 2 integron (gels not shown). 
Figure 13. PCR evaluation of select 
June isolates using primers Int 1-3, 
Lane 1, empty. Lane 2, 100 base pair 
Lambda DNA Ladder. Lane 3, pDU 
intll positive control cell. 
Lane 4, Int 1-3 primer only lane. 
Lane 5 pDU 202 template only lane. 
Lane 6, CC-02-1,. Lane 7, CC-03-1. 
Lane 8, CC-07-1 Lane 9, CC-08-03. 
Lane 10, CC-03-3 . Lane 11, CC-04-3. 
Lane 12, empty. 
Figure 14. PCR evaluation of select 
June islolates using primers Int 1-3. 
Lane 1, empty. Lane 2, 100 base pair 
lambda DNA ladder. Lane 3, pDU 
intll positive control cell. 
Lane 4, Int 1-3 primer only lane. 
Lane 5 pDU 202 template only lane. 
Lane 6, CC-04-4. Lane 7, CC-04-3. 
Lane 8, CC-03-1. Lane 9, CC-04-2. 
Lane 10, CC-01-1. Lane 11, CC-02-2. 
Lane 12, CC-08-2. 
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Figure 15. PCR of June isolates using 
Int 1-3 Forward (F) and Reverse (R) 
primers, forward primer only, or reverse 
primer only. Lane 1, 100 base pair Lamda 
DNA ladder. Lane 2, Tn7 Int12 positive 
Control cell with Int 1-3 F and R primers. 
Lane 3,Tn7 with Int 1-3 F primer only 
Lane 4, Tn7 with Int 1-3 R primer only. 
Lane 5, Int 1-3 F and R primers only lane. 
Lane 6, Tn7 template only lane. Lane 7, 
CC-01-1. Lane 8, CC-03-2. Lane 9, 
CC-04-4. Lane 10, CC-08-2. Lane 11, 
CC-04-3. Lane 12, CC-02-2. 
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Figure 16. PCR of June isolates using 
Int 1-3 Forward (F) and Reverse (R) 
primers, forward primer only, or reverse 
primer only. Lane 1, 100 base pair lamda 
DNAladder. Lane 2, Tn7 with Int 1-3 
F and Rprimers. Lane 3, CC-08-3. 
Lane 4, CC-04-1. Lane 5, CC-04-2. 
Lane 6, CC-03-3. Lane 7, CC-02-3. 
Lane 8, CC-08-3. Lane 9, CC-01-02. 
Lane 10 CC-04-2. Lane 11, CC-07-1 
Lane 12 CC-02-1. Lanes 3-12 contained 
Int 1-3 forward and reverse primers. 
Figure 17. PCR of June isolates using 
Int 1-3 Forward (F) and Reverse (R) 
primers, forward primer only, or 
Reverse primer only. Lane I, empty. 
Lane 2, I 00 base pair lambda DNA ladder. 
Lane 3, CC-01-1, F and R primers. 
Lane 4, CC-01-1 F primer only. 
Lane 5, CC-01-1 R primer only. 
Lane 6, CC-03-2 F and R primers. 
Lane 7, CC-03-2 F primer only. 
-Lane 8, CC-03-2 R primer only. 
Lane 9, CC-04-4 F and Rprimers. 
Lane I 0, CC-04-4 F primer only. 
Lane 11, CC-04-4 R primer only. 
Lane12 empty. 
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Figure 18. PCR of June isolates using 
1-3 Forward (F) and Reverse (R) 
primers, forward primer only, or reverse 
primer only. Lane I, empty. Lane 2, 
100 base pair lamda DNA ladder. 
Lane 3, CC-08-3 F and R primers. 
Lane 4, CC-08-3 F primer only. 
Lane 5, CC-08-3 R primer only. 
Lane 6, CC-04-2 F and R primers. 
Lane 7, CC-04-2 F primer only. 
Lane 8, CC-04-2 R primer only. 
Lane 9, CC-03-3 F and R primers. 
Lane 10, CC-03-3 F primer only. 
Lane 11, CC-03-3 R primer only. 
Lane 12, empty. 
Figure 19. PCR of June isolates using 
Int 1-3 forward (F) and reverse (R) 
primers, forward primer only, and 
reverse only primer. Lane 1, empty. 
Lane 2, 100 base pair lambda DNA 
ladder. Lane 3, CC-08-2 F and R Primers. 
Lane 4, CC-08-2 F only. 
Lane 5, CC-08-2 R primer only. 
Lane 6, CC-04-3 F and R primers. 
Lane 7, CC-04-3 F primer only. 
Lane 8, CC-04-3 R primer only. 
Lane 9, CC-02-2 F and R primers. 
Lane 10 CC-02-2 F primer only. 
Lane 11 CC-02-2 R primer only. 
Lane 12, empty. 
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Figure 20. PCR of June isolates using 
Int 1-3 forward (F) and reverse (R) 
primers, forward primer only, and 
reverse primer only. Lane 1, empty. 
Lane 2, I 00 base pair lambda DNA 
Ladder. Lane 3, CC-04-1 F and R primer. 
Lane 4, CC-02-3 F and R primer. 
Lane 5, CC-02-3 F primer only. 
Lane 6, CC-02-3 R primer only. 
Lane 7, CC-08-2 F and R primers. 
Lane 8, CC-08-2 F primer only. 
Lane 9, CC-08-2 R primer only. 
Lane I 0, CC-02-1 F and R primers. 
Lane 11, CC-02-1 F primer only. 
Lane 12, CC-02-1 R primer only. · 
Figure 21. PCR with pDU 202, Int11 
Positive control cell, using primers 
Int 1-3 and primers Int A and Int B and 
! IE and 13B, 16srDNA primers. 
Lane 1, empty. Lane 2, 100 base pair 
lambda DNA ladder. Lane 3, Intl-3 
primers only. Lane 4, pDU 202 
template only. Lane 6, pDU 202 
Int 1- 3 forward and reverse primers. 
lane 7, pDU 202 Int 1-3 forward primer 
only. Lane 8, pDU 202 reverse primer 
only. Lane 9, pDU 202 forward plus 
2X reverse primer. Lane 10, pDU 202 
primers Int A and Int B. Lane 11, 
pDU 202 primers l!E and 13 B. 
Lane 12, empty. 
Figure 22. PCR on select November 
isolates. Lane!, empty. Lane 2, 100 
~base pair lambda DNA ladder. 
Lane 3, Int A and Int B primers only 
lane. Lane 4, pDU 202 template DNA 
only. Lane 5, pDU Int11 positive 
control cell, with Int A and Int B. 
Lane 6, pDU 202 with postive control 
primers l IE and 13 B. Lane 7, 
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TC-05-1, Int A and Int !;I .. Land 8, 
TC-05-1, I IE and 13B. Lane 9, CC-07-1 
Int A and Int B. Lane 10, CC-07-1, I IE 
and 13 B. Lane 11, CC-01-1, with Int A 
and Int B. Lane 12, CC-02-2 with Int A 
and IntB primers. Lane 11 and 12 contain 
June isolates that gave a potential 
postiveresult using Int 1-3 primers. 
Figure 23. PCR on select March isolates 
Using primers Int 1-3 forward and reverse. 
Lane 1, pDU 202. int/I positi,·c control cell. 
Lane 2, 100 base pair lamhda D'\:\ ladder. 
Lane 3, TC-03-1. Lane -1. TC-03-2. 
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Figure 24. PCR repeat of select March, 
November, and June isolates Using Int A 
and Int B primers. Lane 1, empty. 
Lane 2, 100 base pair lambda DNA 
Ladder. Lane 3, pDU 202, intll positve 
Control cell. Lane 4, Int A and Int B 
primers only lime. Lane 5, Christy fields 
farmers March. Lane 6, TC-03-1 March. 
Figure 25. PCR repeat of select 
June isolates. Lane 1, empty. Lane 2, 
I 00 base pair lambda DNA ladder. 
Lane 3, CC-04-2. Lane 4, CC-01-1. 
Lane 5, CC-03-2. Lane 6, CC-02-3. 
Lane 7, CC-02-1. Lane 8, CC-08-3. 
Lane 9, CC-08-2. Lane 10, CC-08-1. 
Lane 11, CC-07-1. 
Lane 7, TC-2-2 November isolate. Lane 8, 
TC-01-1 November isolate. Lane 9, TC-02-2. 
Lane 10, CC-04-4 June isolate. Lane 11, CC-04-3 
June isolate. 
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a Primers Int 1-3 Forward and Reverse primers were used for 
PCR unless Int A and Int B are indicated. 
1Int 1-3 Reverse primer only was used. 
2
Primers Int A and Int B 
used in PCR reaction. 3 cc:01-1, from November collection period. 
All other isolates from June collection period. 
4
pDU 202, IntII positive 
control cell. 5Tn7, Int12 positive control cell. 
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Table 29 continued. Class I integron PCR product Size for 
Figures 15-24. Isolates are from the June collection period. 
PCR Product Size 
a 
Isolate Figure (Base pairs) 
CC-04-3 15 1100 
17 310 
20 280 
CC-04-4 16 1090 
17 1200,310 
18 I 160,410 
CC-07-1 15 1125 
CC-08-1 16 1100 
17 1200 
21 280 
CC-08-2 16 1090 
CC-08-3 15 1460,930 
18 1020,310 
19 1080,280 




Int 1-3 R 23 1100 
Int A/IntB2 23 900 
Int A/IntB2 24 900 
Tn75 18 1150 
Int 1-3 R 17 1165 
a Primers Int 1-3 Forward and Reverse primers were used for 
PCR unless Int A and Int B are indicated. 
1Int 1-3 Reverse primer only was used. 2Primers Int A and Int B 
used in PCR reaction. 3 CC-07-1, from November collection period. 
All other isolates from June collection period. 4pDU 202, Intll positive 
control cell. 5Tn7, Intl2 positive cqntrol cell. 
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Table 30. Presumptive class I integron positive fecal colifom1s. 
Collection Date 
Isolate (Intl I+) Organism 
11-22-30 





TC-03-1 Enterobacter cloaca CZ (R), AM (R) 









Eschericha coli S, CZ, AM 
CXM (!) 
K(R), D(R), TE(R) 
CB (I) , AM(!) 
CXM (I), AM (I) 
CZ(!) 
CZ(I) 











• Streptomycin (S), Trimethoprim (TMP), Cefazolin (CZ), Piperacillin (Pip), 
Kanomycin (K), Cefuroxime (CXM),.Ampicillin (AM). 
Intermediate Resistance (I), Resistant I. 
b An FC:FS ration of0.7-4.0 indicates a mix of human and animal fecal 
contamination. A ratio less than 0.7 is predominately animal and a ratio above 
4.0 indicates mainly fecal contamination predominately of human origin. 




Two objectives of this study were to determine the density of total coliforms 
(TC), fecal coliforms (FC), and fecal streptococci (FS) bacteria in the Triplett Creek 
watershed and to determine the source of contamination by generating fecal coliform: 
fecal streptococci (FC:FS) ratios. However, because there is some question as to the 
survival rate of fecal streptococci in the environment the reliability of the FC:FS ratio 
has been questioned. 
According to the Environmental Protection Agency's (EPA) standards for 
recreational bodies of water, waters that exhibit FC counts greater than or equal to 
400/1 00mL should be closed to swimming and those that exhibit FC counts greater 
than or equal to 2000/IO0mL should be closed to all activity. The results of the 
bacteriological analysis indicated that during the seven sampling periods, 17 sites 
exhibited fecal coliform (FC) counts equal to or exceeding 400/1 00mL. Of these 17, 
four of the sites, BB-03, DC-03, TC-03 and TC-10, exhibited FC counts equal to or 
greater than 1000/l00mL. Two of the sites, TC-01 and TC-10 exhibited FC counts of 
3100/IOOmL and 3040/1 00mL, respectively. In addition, 42% of the collected 
samples exhibited contamination predominately animal in origin, 50% of the samples 
exhibited contamination from a mix of human and animal wastes, and 8% of the 
collected samples exhibited contamination from a presumptive human source. 
Various factors can influence both the high FC counts as well as the source of 
the contamination. The amount of rainfall for example, can result in increased runoff 
from the watershed and lead to an increased amount of animal fecal material in the 
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stream. Failed septic systems and direct deposition of sewage via straight-line pipes 
also contribute to the high FC counts and result in contamination from a human 
source. 
The sample area, much of which is located in or near a national forest, is a 
rural farm community with a history of contamination from failed or inadequate 
septic systems and deposition of waste directly into the watershed via straight pipes. 
Although the exact source of the fecal contamination and resulting high fecal 
coliform counts cannot be determined from this study, the presence of high fecal 
coliform counts, possibly from a human source, indicates the p·otential for the 
presence of serious pathogens. 
However if straight pipe sewage was continuously deposited into the 
watershed, the FC:FS ratio should be greater than 4.0 during a dry period. For sites 
TC-08, TC-08 and TC-06, sampled in November, following a dry period, the FC 
counts indicated possible contamination from a mix of human and animal sources 
(TC-08 and TC-09) and contamination predominately human in origin (TC-06). 
Thus, it is possible that at sites TC-06, there was a significant and continuously 
inflow of human fecal material into the watershed and perhaps some amount of 
human contamination at TC-08 and TC-09 during the September 23, 2002 sample 
period. TC-06 did not exhibit contamination of human origin during the four 
additional times the site was sampled. In fact, even though the same eight sites 
exhibited considerably higher overall bacterial counts during the wet period; the 
FC:FS ratio of site TC-06 indicated mostly animal contamination. Also, sites TC-08 
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and TC_-09 were predominately animal. This could be explained by the increased 
amount of runoff entering the watershed during the wet period, washing microbes 
from farms, pastures, etc., into the drainage. In fact, the majority of the sites sampled 
during the wet period exhibited FC: FS ratios indicative of animal or a mix of human 
and animal contamination. One site sampled during the wet period, TC-03, did 
however exhibit a FC: FS ratio of 5.50, which is indicative of human contamination. 
TC-03 did not exhibit contamination of human origin the additional four times the 
site was sampled. 
In addition to the bacteriological analysis, another objective of the study was 
to assess select FC isolates for resistance to 6-7 classes of antibiotics using the Kirby 
-Bauer disc diffusion method. Multidrug resistance was defined in this study as 
resistance to two or more classes of antibiotics. The results of the antibiotic analysis 
indicated that 23.5% (31 of 132) of the isolates testeu exhihited multidrug resistance. 
Ampicillin resistance was the most prevalent. with ]II.I"" of the isolates exhibiting 
resistance, and streptomycin the second most pre,-:llcnt "ith 2-U,% of isolates 
exhibiting resistance. 
However. if resistance is viewed in terms of those isolates collected from sites 
exhibiting contamination from primarily a human source or animal source 
contamination, there is a greater percentage of multi drug resistance among those 
isolates from potentially human contaminated sites (Table 29). 66.7% of the isolates 
from sites with potential human waste were resistant to two or more classes, whereas 
only 6.1 % of the isolates from sites with predominately animal waste were multidrug 
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resistant. In addition, 20% of the isolates from human contaminated sites exhibited 
resistance to four classes of antibiotics while none of the isolates from animal 
contaminated sites were resistant to more than three classes. There also appears to be 
a prominent difference in the individual antibiotic resistance patterns between isolates 
from the two source types. Isolates from sites with potential human _waste displayed 
a much higher percentage of resistance to aminoglycosides, a first generation 
cephalosporin, and penicillin's than did the other isolates. Perhaps the most 
significant difference was observed with sulfonamide resistance. 45.5% of the 
isolates from sites with probable human waste exhibited trimethoprim resistance 
while none of the isolates from sites with predominately animal material were 
resistant to the sulfonamide. This is especially noteworthy because trimethoprim is 
used frequently in a clinical setting in the treatment of urinary tract infections. 
Resistance to trimethoprim is often attributed to alternative forms of the dihydrofolate 
reductase gene (DHFR). Because these genes are commonly found on plasmids or 
associated with transposable elements and integrons, they have a high potential for 
transfer. 
Although the exact mechanism(s) resulting in the antibiotic resistance 
observed cannot be determined from this study, it is clear that multidrug resistance 
does exist in environmental isolates. In addition, the distinct difference in resistance 
patterns between those isolates from samples that exhibited FC:FS ratios indicative of 
human fecal contamination and those from samples with predominately animal 
wastes, might lend further support for the validity of the FC:FS ratio itself. 
Multiple drug resistance is prevalent and has been highly correlated to the 
presence ofintegrons in clinical enteric isolates. Few studies however, have 
addressed the role integrons might play in multi drug resistance associated with 
environmental enteric isolates. 
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Polymerase chain reaction was therefore used to detect the presence of class 1 
and class 2 integons in select fecal coliforms isolated from the Triplett Creek 
watershed. Two sets of primers, both corresponding to the conserved regions· of inti 
1, were used to evaluate the isolates for the presence of class 1 integrons. When 
using Int 1-3 forward and reverse primers, a larger band was observed in both the 
positive control cell and many ofthe isolates that produced the expected 280 base pair 
product. Also, the reverse primer only gave a larger product in both the control cell 
and many of the isolates tested. Thus, the larger product observed could be reverse 
primer dependent. The length of the product would also be dependent upon the 
specific PCR conditions, specifically the annealing temperature/time and the number 
of cycles. It is possible that the annealing temperature was to low and the less 
stringent conditions allowed less specific base pairing to occur. It is also possible that 
the primer concentration was not optimal or that perhaps the forward primer was 
being degraded and the reverse primer was then pulling up most of the inti 1 gene, 
resulting in a product size approximately 975 base pairs in length. Because insertion 
sequences (IS) often flank the 5' end of the gene it is also possible that larger 
fragments could result from amplification of the 975 base pairs of the inti 1 gene and 
the the IS, which could vary in length (Table 29). 
Another explanation could be that two class 1 integrons are present and 
oriented such that the 5' ends of the integrase genes are adjacent (Figure 27). 
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Nine of the 126 isolates tested (7 .1 % ) appeared to contain a class 1 integron 
while none of the isolates contained a class 2 integron. Although most of the 
isolates did exhibit intermediate level resistance only three exhibited resistance to the 
antibiotics tested. It is not uncommon to find empty integrons, integrons lacking 
integrated gene cassettes, in environmental isolates Rosser. One explanation is that 
the cassettes were lost when the selection pressure of the antibiotic was absent or 
because in the environment the selection pressure is absent or not great there is no 
need to integrate the cassettes in the first place. Thus in the environment, where the 
antibiotic is typically not present or not encountered in significant amounts, those 
isolates containing integrons with integrated cassettes posses no selective advantage 
over those isolates that do not possess them. 
The presence of the integron and lack of a resistant phenotype in the isolates 
could also be explained by the type of promoter contained in the integron. Two types 
of promoters have been described in class 1 integrons, Pl and P2. Pl promoters are 
further subdivided based on weak CJr strong expression and P2 promoters are either 
active or inactive. Thus, it is possible that the integrons carried an inactive or weak 
promoter and tl;ie resistant cassettes were either not expressed at all or not expressed 
at a level sufficient to result ·in resistance. 
Similar studies have also reported the presence of multidrug resistant isolates 
1013 bp 
3' int! I 




I 013 bp 
int! I 3' - +- > ~ 
1950 hp.without IS present 
Approximately 975 bp 
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Product size would vary depending upon IS length 
Figure 26. Potential products that could result from amplification with Int-1-3 
reverse primer. Blue. boxed arrows represent the class I integrase genes, int! 1, 
which is 1012 base pairs in length. Int 1-3 Forward primer is represented by 
the gray arrow and Intl-3 Reverse primer is indicated by the black arrow. The 
long black arrows indicate how the reverse primer might result in the multiple 
product sizes. IS, Insertion sequence. 
in the environment and found a low incidence of integrons associated with those 
isolates. Roe et al., evaluated 322 E. coli isolates from irrigation waters and sediment 
for multiple antibiotic resistance and for the presence of class I and class 2 integron. 
They reported that I 0% of the isolates tested were resistant to two or more antibiotics 
and 13% exhibited a positive PCR result for the intJI gene and one isolate appeared 
to contain the int12 gene. After sequence analysis of the variable regions of three of 
the four integrons, it was concluded they contained an aadAJ and sat-I gene cassette. 
However, none of isolates were phenotypically resistant to streptomycin. Thus, 
although they contained the cassettes they appeared not to express them (33). 
As indicated, Rosser et al., looked at environmental isolates from an estuarine 
environment and reported only 3.6% of the isolates contained a class I integron (34). 
It is clear that bacteria have access to a suit of resistance genes and possess a 
variety of mechanisms to mobilize those genes, thus enabling their transfer from one 
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genetic element to another and/or from one cell to another. It is also clear that 
antibiotic resistance and multidrug resistance is becoming more prevalent. Multiple 
drug resistance and integrons appear not to occur at the same frequency in 
environmental enteric isolates as they do in clinical isolates, being more prevalent in 
the latter. Although it is unclear the rate at which the transfer of such genes or mobile 
genetic elements occurs in the .environment, the presence of multiple drug resistant 
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